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ABSTRACT 
 
“A National Study of Health Behaviors and Health-Related Quality of Life Among 
Survivors of Breast, Prostate, and Colorectal Cancer Compared to Propensity Score 
Matched Controls, as well as, Comparisons by Cancer Type & Gender” 
 
 
Traci J. LeMasters 
 
Among the 12 million cancer survivors currently living in the U.S., over half are comprised of 
survivors of breast (22%), prostate (20%), and colorectal cancers (9%).  While about 2/3 of 
cancer survivors are living longer than 5 years since the time of diagnosis, many continue to 
experience late or long-lasting symptoms and effects of the cancer and its treatment that often 
negatively affect their Health-Related Quality of Life (HRQOL).  What is more, previous 
research has observed that many survivors are further burdened with a greater number of obesity 
related chronic and co-morbid health conditions compared to those without a history of cancer.  
In fact, over 70% of breast, prostate, and colorectal cancer survivors have been found to be 
overweight or obese.  However, despite having had a health scare that many may consider a cue 
to action, studies have shown that most cancer survivors do not engage in healthy behaviors at 
levels superior to those without a history of cancer.  Previous studies of HRQOL and health 
behaviors among cancer survivors have been limited by small sample size and samples of cancer 
survivors limited by age and/or time since diagnosis.  Furthermore, studies that made 
comparisons using non-cancer controls primarily matched on age and gender alone, or nothing at 
all, thus not rigorously controlling for confounding bias.  Finally, no study has comprehensively 
compared HRQOL and health behaviors among the largest groups of survivors to stringently 
matched controls to understand clearly how survivors of breast, prostate and colorectal cancer 
may differ from those without a history of cancer, while also comparing these outcomes by type 
of cancer and gender to clearly understand how these outcomes may vary between cancer 
survivors and genders.  Therefore, the objectives of this study were to 1) compare the prevalence 
of specific measures of HRQOL between breast, prostate, female, and male colorectal cancer 
survivors to propensity score matched controls, and to compare HRQOL by type of cancer and 
gender and 2) compare the prevalence of specific health conditions and health behaviors between 
breast, prostate, female, and male colorectal cancer survivors to propensity score matched 
controls, and to compare health behaviors by type of cancer and gender.  A cross-sectional study 
was conducted using a sample of breast, prostate, and colorectal cancer survivors 18 years of age 
and older and > 1 year past diagnosis were selected from the 2009 BRFSS.  A greedy algorithm 
and matching without replacement used propensity scores to match 3 controls to every 1 case on 
age, gender, race/ethnicity, income, insurance status, and region of the U.S. HRQOL measures 
compared were life satisfaction, perceived emotional support, activity limitations, perceived 
general, physical and mental health, and sleep quality.  Health conditions compared were 
arthritis, asthma, heart disease, diabetes, hypertension, high cholesterol, stroke, activity 
limitations, and perceived general health.  Health behaviors compared were flu immunization, 
physical check-up, cholesterol check, BMI, physical activity, fruit and vegetable consumption, 
smoking, and alcohol use.  Chi-square tests were used to test for covariate balance and compared 
prevalence of health conditions and behaviors.  Binomial and multinomial logistic regression 
models were used to estimate the probabilities of behaviors for cancer cases compared to 
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controls.  The final study sample consisted of 6,393 breast, 3,636 prostate, 1,111 female 
colorectal, and 824 male colorectal cancer survivors.  Compared to matched controls, cancer 
survivors were up to 3.67 times more likely (95%CI: 2.09, 6.47) at 1 – 5 years since diagnosis, 
and up to 1.91 times more likely (95%CI: 1.30, 2.79). Breast, female, and male colorectal cancer 
survivors were up to 2.62 times more likely (95%CI: 1.72, 3.99) to report activity limitations 
compared to matched controls.  Additionally, colorectal cancer survivors were more likely to 
report worse physical health than their matched controls.  Male colorectal and prostate cancer 
survivors were more likely to report worse mental health, and prostate cancer survivors were 
more likely to report a lack of emotional support and not enough sleep compared to their 
matched controls.  Comparisons by cancer type found that male colorectal cancer survivors were 
more likely to report activity limitations and perceive their general and physical health to be 
worse than prostate cancer survivors.  Gender comparisons found that females were more likely 
to hold poorer perceptions of their general, physical, and mental health, report not enough sleep, 
and not receiving enough emotional support, but more likely to be satisfied with life.  Breast and 
prostate cancer survivors reported a greater prevalence of chronic health conditions than matched 
controls.  Breast cancer survivors were more likely to engage in healthier behaviors 1 – 5 years 
after diagnosis, but were more likely to be obese at > 5 years after diagnosis than controls.  Male 
colorectal cancer survivors were less likely to engage in clinical preventive care at > 5 years after 
diagnosis than controls.  Female colorectal and breast cancer survivors were less likely be 
overweight and/or obese, former and/or current smokers, drink any alcohol, and more likely to 
consume > 5 servings of fruits and vegetables per day, but more likely to engage in none or 
insufficient levels of physical activity compared to male colorectal and prostate cancer survivors, 
respectively.  All cancer survivor groups reported more limitations and held poorer perceptions 
of their general health.  Differences between matched controls for other HRQOL measure vary 
by type of cancer, although compared to similar males without cancer, male cancer survivors 
reported worse outcomes on measures such as mental health, sleep, and emotional support. 
However, when female survivors were compared to male survivors, females reported worse 
outcomes for all measures except life satisfaction.  Breast and prostate cancer survivors have 
more chronic health conditions compared to matched controls than do female and male 
colorectal cancer survivors.  Breast cancer survivors are more likely to engage in healthy 
behaviors than their matched controls.  Female cancer survivors engage healthier lifestyle 
behaviors, with the exception of physical activity, compared to male cancer survivors. 
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CHAPTER 1 
Introduction 
 An individual is considered to be a “cancer survivor” from the time of their cancer 
diagnosis throughout the rest of their life 
1
.  Nearing 12 million, the number of cancer survivors 
alive in the U.S. today is greater than ever before.  This growing population can be attributed to 
increased adoption of regular cancer screenings, advances in cancer detections and treatments, as 
well as an aging population 
1 & 2
.  Not only is the number of cancer survivors increasing, but also 
the number of cancer survivors living 5 years or longer.  As of 2008, about 66% of the cancer 
survivors were living 5 or more years post diagnosis 
3
.  Survivors of breast (22%), prostate 
(20%), and colorectal cancers (9%) consist of the three largest groups of cancer survivors in the 
U.S. 
3
.    
 In spite of improved survival rates, many survivors continue to experience long lasting 
symptoms and or late effects of the cancer and its treatment which can negatively affect their 
physical and mental health, psychosocial well-being, functional status, and consequently their 
health-related quality of life (HRQOL)
 4 – 10
.   Specific symptoms and effects commonly 
experienced by cancer survivors include problems with physical functioning, chronic pain, 
lymph edema, cognitive impairment, fatigue, sleep disturbances, depression, anxiety, sexual 
dysfunction, and infertility.  Whether these sequelae are a result of the malignancy itself, surgery 
to the cancer site, chemotherapy, radiation, adjuvant therapy, or just owing to the distress of the 
cancer experience, these problems can persist for many years, remaining unresolved and even 
untreated for a large number of cancer survivors 
4, 5, 8, 11 – 15
.  Moreover, when compared to their 
age matched non cancer controls, many survivors report lower scores in one or more domains of 
HRQOL 
16 & 17
. 
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 What is more, rates of obesity have been reportedly high among certain groups of 
survivors, with prevalence as high as 70% among survivors of breast, prostate, and colorectal 
cancer, increasing their risk of developing obesity related chronic and co-morbid conditions 
3, 18 – 
21
.  In fact, when compared to age-matched non cancer controls, cancer survivors exhibit a 
greater number of obesity related chronic and co-morbid conditions further worsening their 
health and HRQOL 
 22 & 23
.  Despite this revelation and having had a health scare that some 
would consider a “cue to action”, many cancer survivors do not meet levels of dietary intake or 
physical activity as recommended by the American Cancer Society 
24 & 25
, nor do they engage in 
superior levels of these and other health behaviors than their age-matched non cancer controls 
22, 
26, 27
, even though they have been shown to enhance cancer survival, decrease the risk of cancer 
recurrence, decrease the risk of all-cause mortality, increase functional status and overall health, 
and subsequently, improve HRQOL
24, 28 – 31
.  Furthermore, while cancer survivors may engage in 
greater levels of recommended cancer screenings, they do not differ from non cancer controls in 
receipt of general clinical preventive care 
32 & 33
.   
Statement of Problem 
 The late and long lasting symptoms and effects following treatment for cancer that are 
experienced by many survivors are issues that remain unresolved or untreated and are known to 
have detrimental effects upon their HRQOL.  Further affecting HRQOL and functional status are 
the high rates of chronic and co-morbid conditions associated with obesity among certain groups 
of survivors.  Previous work has identified how these post-treatment sequelae affecting HROL 
can differ in prevalence and severity by age, race, income, metro status, level of social and 
emotional support, time since diagnosis, and type of treatment, but little research has directly 
compared how domains of HRQOL may differ from controls rigorously matched on known 
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confounders and how these domains may vary type of cancer and gender 
8 – 10, 34 – 41
.  Similarly, 
studies of health behaviors and clinical preventive care among cancer survivors have identified 
variations by age, race, and education.  However, few studies have compared how HRQOL and 
health behaviors among breast, prostate, and colorectal cancer survivors may differ from 
rigorously matched controls or between types of cancers and genders 
7, 22, 23, 26, 40, 42
.   
 Given that, survivors of breast, prostate, and colorectal cancer comprise over 50% of the 
cancer survivor population, it is important to understand how affected HROL domains may vary 
from those without a history of cancer and by cancer type and gender in order to address any 
unmet individual health care needs 
3
.  Furthermore, with up to 70% of breast, prostate and 
colorectal cancer survivors reported to be overweight and/or obese, it is imperative to identify if 
these specific groups are indeed burdened with a high number of chronic and co-morbid 
conditions as the literature has suggested and assess which health behaviors to target for 
improvement.   
 To address these unmet and increasing needs of a growing population, this project will 
conduct two separate studies, one that is focused on HRQOL and the other upon health and 
health behaviors.   
Conceptual Framework 
 The conceptual framework of these two studies will be based upon the final Andersen 
Behavioral Model of Health Services Use.  Originally developed by Ronald M. Andersen in the 
1960’s, the initial version of the model was intended to determine what either facilitates or 
impedes a family’s use health services, define and measure equal access to health care services, 
and to aid in policy development for equal access to health care services.  The model then shifted 
to focus on the individual as the unit of analysis rather than the family, due to its difficulty to 
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measure.  This first phase examined how predisposing characteristics, enabling resources, and 
need for care were related to the use of health care services.  Predisposing characteristics 
encompasses measures of demographics (age, race, gender, ect.), social structure (education, 
occupation, ect.), and health beliefs (attitudes, values, and beliefs about health services).  
Enabling resources measure access via personal/family characteristics (marital status, income, 
insurance, usual source of care, available transportation, ect.) and community characteristics (ex. 
number of health care facilities and providers in the area).  Measures of need include the 
individual’s perceived need for services as well as evaluated health status 43.   
 The second phase of the model was adapted to include characteristics of the health care 
system and their relation to utilization of health care services.  Characteristics of the health care 
system include national health policy, resources, and organization of the health care system.  
This phase also included consumer satisfaction as an outcome, as well as distinguishing types of 
health services use by type, site, purpose, and by coordination of services used for a particular 
episode of service 
43
.   
 The third phase of the model includes the external environment (physical, political, and 
economic) as a factor related to utilization of health care services.  In this phase, the model was 
also adapted to include the relation of personal health practices (diet, exercise, ect.) to health care 
utilization and to health outcomes, also added to the model.  Health outcomes included perceived 
health status, evaluated health status, and consumer satisfaction, allowing researchers and policy 
makers to understand the relationship between health care service utilization, health status, and 
consumer satisfaction 
43
.   
 The fourth and fifth phases of the model were modified to include feedback loops that 
demonstrate how outcomes affect population characteristics, perceptions, and health behaviors, 
5 
 
allowing for a more accurate depiction of the interaction between various factors, rather than just 
a linear relationship to outcomes.  It was further modified to place more emphasis on the 
individual and contextual determinants of health care service utilization.  The framework for the 
currently proposed studies will utilize the fourth phase of the Andersen model (Figure 1).   
Figure 1. Phase 4 of the Andersen Behavioral Model of Health Service Use 
 
 The initial creation of the model was intended to identify conditions that either facilitate 
or impede utilization of health services using a national survey administered by the Center for 
Health Administration Studies and the National Opinion Research Center, and since then the 
model has been broadly used in studies utilizing data from other national health surveys 
43 & 44
.  
The model’s fundamental purpose is to identify what facilitates and/or impedes health care 
service utilization by studying the interrelationships between an individual’s contextual 
characteristics, individual characteristics, health behaviors, and outcomes in order to help direct 
national health care policy.  The Centers for Disease Control and Prevention’s (CDC) Behavioral 
Risk Factor Surveillance System (BRFSS) survey is one such national survey that if often used 
in studies guided by the Behavioral Model of Health Service Use.  The BRFSS collects 
information on health care access related to chronic disease and injury, preventive health care 
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practices, and risky health behaviors.  It also collects information on perceived and evaluated 
health status, sociodemographic and environmental characteristics.  
 Using data provided by the 2009 BRFSS questionnaire 
45
, the first study will examine 
association between environmental, predisposing, enabling, and need factors and HRQOL 
outcomes between survivors of breast, prostate, colorectal cancer survivors and propensity score 
matched controls and by type of cancer and gender.  Environmental factors studied will be region 
of United States and metro status.  Predisposing characteristics will include age, gender, race, 
and education.  Enabling factors will be comprised of employment status, insurance status, 
income, usual source of care, marital status, and emotional support.  Measures of need will be 
presence of cancer, type of cancer, time since diagnosis, presence of heart disease, diabetes, 
hypertension, high cholesterol, stroke, asthma, and arthritis.  HRQOL outcomes will be 
measured by perceived general health status, activity limitations, perceived number of healthy 
physical days in the past month, perceived number of healthy mental health days in the past 
month, perceived number days of not enough sleep in the past month, emotional support, and life 
satisfaction.   
 The second study will examine the association between environmental, predisposing, 
enabling, and need factors and health behaviors between survivors of breast, prostate, colorectal 
cancer survivors and propensity score matched controls and by type of cancer and gender.  
Environmental factors studied will be region of United States and metro status.  Predisposing 
characteristics will include age, gender race, and education.  Enabling factors will be comprised 
of employment status, insurance status, income, usual source of care, and marital status.  
Measures of need will be presence of cancer, type of cancer, time since diagnosis, presence of 
heart disease, diabetes, hypertension, high cholesterol, stroke, asthma, and arthritis.  Measures of 
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health behaviors will be categorized by lifestyle behaviors and general clinical preventive care 
utilization.  Lifestyle behaviors include, physical activity, nutritional intake, BMI, tobacco use, 
and alcohol use.  General clinical preventive care includes last routine check-up, last cholesterol 
check, and last flu immunization.   
Aims & Objectives 
Study 1 
Aim 1:  To compare measures of HRQOL, specifically activity limitations, perceived general 
health, perceived physical health, perceived mental health, perceived amount of sleep, emotional 
support, and life satisfaction, between breast, prostate, colorectal cancer survivors and propensity 
score matched controls matched for age, gender, race/ethnicity, income, insurance status, and 
region of the U.S.      
Objective 1.1:  To determine significant differences between measures of HRQOL, specifically 
activity limitations, perceived general health, perceived physical health, perceived mental health, 
perceived amount of sleep, emotional support, and life satisfaction, between breast, prostate, 
colorectal cancer survivors and propensity score matched controls. 
Objective 1.2:  To estimate the likelihood of HRQOL outcomes, specifically activity limitations, 
perceived general health, perceived physical health, perceived mental health, perceived amount 
of sleep, emotional support, and life satisfaction, for breast, prostate, colorectal cancer survivors 
compared to propensity score matched controls by time since diagnosis. 
Aim 2:  To compare measures of HRQOL, specifically activity limitations, perceived general 
health, perceived physical health, perceived mental health, perceived amount of sleep, emotional 
support, and life satisfaction, between survivors of breast, prostate, and colorectal cancers by 
type of cancer and gender.  
8 
 
Objective 2.1:  To estimate the likelihood of HRQOL outcomes, specifically activity limitations, 
perceived general health, perceived physical health, perceived mental health, perceived amount 
of sleep, emotional support and life satisfaction, for survivors of breast cancer compared to 
female survivors of colorectal cancer and for survivors of prostate cancer compared to male 
survivors of colorectal cancer.  
Objective 2.2:  To estimate the likelihood of HRQOL outcomes, specifically activity limitations, 
perceived general health, perceived physical health, perceived mental health, perceived amount 
of sleep, emotional support, and life satisfaction, for female survivors of a gender-neutral 
(colorectal) cancer compared to male survivor of a gender-neutral (colorectal) cancer.  
Objective 2.3:   To estimate the likelihood of HRQOL outcomes, specifically activity limitations, 
perceived general health, perceived physical health, perceived mental health, perceived amount 
of sleep, emotional support, and life satisfaction, for survivors of a female-specific (breast) 
compared to male-specific (prostate) cancer.   
Study 2 
Aim 1:  To compare differences in evaluated health status, specifically perceived general health, 
activity limitations, prevalence of certain chronic conditions and number of co-morbid or chronic 
conditions, and health behaviors, specifically level of physical activity, nutritional intake, BMI, 
tobacco use, alcohol use, and general clinical preventive care, between breast, prostate, 
colorectal cancer survivors and propensity score matched controls matched for age, gender, 
race/ethnicity, income, insurance status, and region of the U.S.      
Objective 1.1:  To determine significant differences in evaluated health status, specifically 
perceived general health, activity limitations, BMI, prevalence of diabetes, heart disease, 
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hypertension, high cholesterol, stroke, asthma and arthritis between breast, prostate, colorectal 
cancer survivors and propensity score matched controls. 
Objective 1.2:  To significant differences in health behaviors, specifically level of physical 
activity, nutritional intake, BMI, tobacco use, alcohol use, and general clinical preventive care, 
between breast, prostate, colorectal cancer survivors and propensity score matched controls.   
Objective 1.3:  To estimate the likelihood of health behaviors, specifically level of physical 
activity, nutritional intake, BMI, tobacco use, alcohol use, and general clinical preventive care, 
of breast, prostate, colorectal cancer survivors compared to propensity score matched controls by 
time since diagnosis.   
Aim 2:  To compared differences in health behaviors, specifically level of physical activity, 
nutritional intake, BMI, tobacco use, alcohol use, and general clinical preventive care between 
breast, prostate, colorectal cancer survivors by type of cancer and gender.  
Objective 2.1:  To estimate the likelihood health behaviors, specifically level of physical activity, 
nutritional intake, BMI, tobacco use, alcohol use, and general clinical preventive care, for a 
female-specific (breast) compared to a male-specific (prostate) cancer.   
Objective 2.2:  To estimate the likelihood of health behaviors, specifically level of physical 
activity, nutritional intake, BMI, tobacco use, alcohol use, and general clinical preventive care 
for female survivors of a gender-neutral (colorectal) cancer compared to male survivors of a 
gender-neutral cancer. 
Objective 2.3:   To estimate the likelihood of health behaviors, specifically level of physical 
activity, nutritional intake, BMI, tobacco use, alcohol use, and general clinical preventive care 
for survivors of breast cancer compared to female survivors of colorectal cancer and for 
survivors of prostate cancer compared to male survivors of colorectal cancer. 
10 
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Abstract 
Objectives 
 The objectives of this study were to compare the prevalence of specific measures of 
HRQOL between breast, prostate, female, and male colorectal cancer survivors to propensity 
score matched controls, and to compare HRQOL by type of cancer and gender.  
Methods 
 A cross-sectional study was conducted using a sample of breast, prostate, and colorectal 
cancer survivors 18 years of age and older and > 1 year past diagnosis were selected from the 
2009 BRFSS.   A greedy algorithm and matching without replacement used propensity scores to 
match 3 controls to every 1 case on age, gender, race/ethnicity, income, insurance status, and 
region of the U.S. HRQOL measures compared were life satisfaction, perceived emotional 
support, activity limitations, perceived general, physical and mental health, and sleep quality.  
Chi-square tests were used to test for covariate balance and compared prevalence of health 
conditions and behaviors.  Binomial and multinomial logistic regression models were used to 
estimate the probabilities of behaviors for cancer cases compared to controls.   
Results 
 The final study sample consisted of 6,393 breast, 3,636 prostate, 1,111 female colorectal, 
and 824 male colorectal cancer survivors.  Compared to matched controls, cancer survivors were 
up to 3.67 times more likely (95%CI: 2.09, 6.47) at 1 – 5 years post diagnosis, and up to 1.91 
times more likely > 5 years post diagnosis to perceive their general health to be fair/poor 
(95%CI: 1.30, 2.79). Breast, female, and male colorectal cancer survivors were up to 2.62 times 
more likely (95%CI: 1.72, 3.99) to report activity limitations compared to matched controls.  
Additionally, colorectal cancer survivors were more likely to report worse physical health than 
16 
 
their matched controls.  Male colorectal and prostate cancer survivors were more likely to report 
worse mental health, and prostate cancer survivors were more likely to report a lack of emotional 
support and not enough sleep compared to their matched controls.  Comparisons by cancer type 
found that male colorectal cancer survivors were more likely to report activity limitations and 
perceive their general and physical health to be worse than prostate cancer survivors.  Gender 
comparisons found that females were more likely to hold poorer perceptions of their general, 
physical, and mental health, report not enough sleep, and not receiving enough emotional 
support, but more likely to be satisfied with life.   
Conclusions 
 All cancer survivor groups reported more limitations and held poorer perceptions of their 
general health.  Differences between matched controls for other HRQOL measure vary by type 
of cancer, although compared to similar males without cancer, male cancer survivors reported 
worse outcomes on measures such as mental health, sleep, and emotional support. However, 
when female survivors were compared to male survivors, females reported worse outcomes for 
all measures except life satisfaction.   
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Introduction 
 
 Approaching 12 million strong, cancer survivors are a growing population within the 
United States (U.S.) attributable to increased adoption of regular cancer screenings, advances in 
cancer detections and treatments, as well as an aging population 
1 & 2
.  Not only is the number of 
cancer survivors increasing, but also the number of cancer survivors living 5 years or longer.  As 
of 2008, about 66% of the cancer survivors were living 5 or more years post diagnosis 
3
.  In spite 
of these improved survival rates, many survivors continue to experience long lasting symptoms 
and or late effects of the cancer and its treatment which can negatively affect their physical and 
mental health, psychosocial well-being, functional status, and consequently their health-related 
quality of life (HRQOL)
 4 - 9
.  Common symptoms and treatment effects experienced by cancer 
survivors that can affect HRQOL, defined by Testa & Simonson as the “physical, psychological, 
and social domains of health, seen as distinct areas that are influenced by a person’s experiences, 
beliefs, expectations, and perceptions” 10, may include physical limitations, chronic pain, lymph 
edema, fatigue, sleep disturbances, depression, anxiety, sexual dysfunction, and infertility 
5, 6, 11 – 
15.
.   
 Among cancer survivors living in the U.S., survivors of breast (22%), prostate (20%), and 
colorectal cancer (9%) are the three most numerous groups of survivors 
3
.  Numerous studies 
have examined HRQOL among breast, prostate, or colorectal cancer alone 
16 - 18
.  However, these 
studies did not directly compared measures of HRQOL between survivors of breast, prostate, and 
colorectal cancer to matched non-cancer controls to identify differences between survivors and 
similar individuals without a history of cancer, and/or within cancer survivors to identify 
differences by cancer type and gender.  
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Previous Research 
Comparisons by Cancer Type & Gender 
  Between cancer types,  Deshields and colleagues (2011) observed that among a small 
group of recently diagnosed survivors, colorectal cancer survivors reported a greater prevalence 
of difficulty sleeping (71%) and lack of energy (79%), followed by breast (59% & 71%) and 
then prostate cancer survivors (39% & 41%), respectively.  Yet, breast cancer survivors reported 
a greater prevalence of pain (64%) worrying (53%) and feeling sad (50%), followed by 
colorectal (53%, 38%, and 47%), then prostate cancers survivors (26%, 27%, and 24%), 
respectively 
19
.  In a small group of cancer survivors sampled from the 2000 National Health 
Interview Survey, Yabroff and colleagues (2004) observed that a greater prevalence of colorectal 
(39.9%) and prostate cancer survivors reported limitations (33.7%) compared to breast cancer 
survivors (30.6%), but a greater prevalence of breast (37.4%) and prostate cancer survivors 
(36.6%) perceived their general health status as excellent/very good, compared to colorectal 
cancer survivors (26.2%) 
20
.  Similar findings were observed among a small sample of long-term 
Australian cancer survivors studied by Eakin and colleagues (2006).  Prostate (35.9%) and breast 
cancer survivors (31.7%) more often perceived their general health status to be excellent/very 
good, compared to colorectal cancer survivors (17.9%) 
21
.  However, survivors of breast (38.5%) 
and colorectal cancer (34.8%) had a higher prevalence of moderate/high risk mental health 
scores compared to prostate cancer survivors (24.5%).   
 Concerning gender differences in HRQOL, findings from two studies of quality of life 
among colorectal cancer survivors suggest that females may experience worse physical health, 
mental health, and pain as compared to male cancer survivors 
8 & 22
.   
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Comparisons Between Cancer Survivors and Non-Cancer Controls 
 Compared to those without a history of cancer, Yabroff and colleages (2004) observed 
that breast, prostate, and colorectal cancer survivors reported a greater prevalence of activity 
limitations (39.9% - 30.6% vs. 23.8%) and perceived their general health to be excellent/very 
good less often (26.2% - 37.4% vs. 53.1%) compared to non-cancer controls matched for age, 
gender, and education  
20
.  Eakin and colleagues also observed that survivors of breast, prostate, 
and colorectal cancer perceived their general health to be excellent/very good less than non-
cancer controls (35.9% - 17.9% vs. 45.1%) matched for age and gender 
21
.    
However, survivors of breast (38.5%) and colorectal cancer (34.8%) had a higher prevalence of 
moderate/high risk mental health scores (38.5% & 34.8% vs. 32.6%) compared to non-cancer 
controls, but prostate cancer survivors had a lower prevalence of moderate/high risk mental 
health score (24.5% vs. 32.6%) compared to non-cancer controls 
21
.  Finally, Smith and 
colleagues (2008) observed that among a large, national sample of Medicare beneficiaries, age > 
65 years, survivors of breast, prostate, colorectal cancer had significantly worse physical health 
scores than those without a history of cancer, but only survivors of breast and colorectal cancer 
had significantly worse mental health scores than those without a history of cancer 
23
.    
Statement of the Problem 
 While some consistent findings regarding general health, mental health and activity 
limitations have emerged from the previously described research, it remains unknown how breast 
compared to female colorectal cancer survivors and how prostate compared to male colorectal 
cancer survivors may differ across measures of HRQOL, as colorectal cancer survivors have not 
been compared to other cancer survivors stratified by gender.  Furthermore, these studies have 
been limited in various ways.  Limitations in study design include a small number of HRQOL 
20 
 
measures examined, small sample size, only survivors age > 65 years, only survivors living > 5 
years post diagnosis, and/or studies utilizing a comparison group, used controls not matched to 
cases, or matched only for age and gender or age, gender, and education, and therefore not 
controlling for remaining confounding bias.  Because observational studies are at risk for 
confounding effects due to the lack of randomization inherent to experimental studies, 
researchers should implement methods to control for confounding effect to reduce threats to 
validity.  Reeve et. al. describe how the method of propensity score matching can effectively 
reduce bias in cancer research when utilizing control groups to compare outcomes between 
cancer survivors and those without a history of cancer 
24
.   While traditional methods of matched 
sampling, stratification, and covariate adjustment are often limited by the number of variables 
they can control for and/or are limited by assumptions such as normal distributions and linearity, 
propensity score matching is not limited in these ways.   
 Bearing these thoughts in mind, the aims of this study are to 1) compare the prevalence of 
HRQOL outcome measures, specifically life satisfaction, perceived level of emotional support, 
activity limitations, perceived general health, perceived physical health, perceived mental health, 
and sleep quality between breast, prostate, female colorectal and male colorectal cancer survivors 
to their unique non-cancer control groups matched or age, gender, race/ethnicity, income, 
insurance status, and region of the U.S. using a propensity score; 2) compare the estimated 
probabilities of specific HRQOL outcomes for each cancer type to their propensity score 
matched controls by fitting logistic regression models stratified by time since diagnosis (1 – 5 
years and > 5 years) to examine how these behaviors may change in comparison to matched 
controls over the course of the cancer survivorship continuum; and 3) compare the estimated 
probabilities of specific HRQOL outcomes between cancer types (breast cancer vs. female 
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colorectal and prostate vs. male colorectal) and gender (female vs. male colorectal and breast vs. 
prostate), in order to measures differences in HRQOL associated with cancer type and gender.   
 The current study will utilize Ronald M. Andersen’s Behavioral Model of Health 
Services Use framework to examine the association between environmental, predisposing, 
enabling, need factors, and HRQOL between survivors of breast, prostate, colorectal cancer 
survivors, and propensity score matched controls.  The Behavioral Model of Health Services Use 
is commonly used to guide studies utilizing national health survey data 
25
.  This study will 
analyze a large, nationally representative sample, the 2009 Behavioral Risk Factor Surveillance 
System (BRFSS) population based survey.  The environmental factors assessed are region of 
United States and metro status.  Predisposing characteristics include age, gender, race, education 
and time since diagnosis.  Enabling factors are marital status, employment status, insurance 
status, income, and usual source of care.  Measures of need are presence of cancer, type of 
cancer, presence of arthritis, asthma, diabetes, hypertension, high cholesterol, heart disease, and 
stroke. Measures of HRQOL life satisfaction, perceived level of emotional support, presence of 
activity limitation, perceived general health status, perceived physical health status, perceived 
mental health status, and sleep quality.   
Methods 
Data Source 
 Data analyzed was provided by the 2009 Centers for Disease Control’s national 
Behavioral Risk Factor Surveillance System (BRFSS) survey 
26
.  The BRFSS is an annual, state-
based telephone survey administered to non-institutionalized citizens of all 50 states, the District 
of Columbia, Puerto Rico, the U.S. Virgin Islands, and Guam adults aged 18 years and older.  
The survey collects information pertaining to prevalence of diseases, risky health behaviors, 
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preventive health care utilization, perceived health status, access to health care services, 
sociodemographic, and environmental characteristics.  The core component is a standard set of 
questions administered to all states and territories.  Optional modules, however, collect 
information of specific health topics and are up to the discretion of each state as to whether they 
will be administered.  Moreover, additional questions that are not evaluated by the CDC may be 
added to the questionnaire by individual states.  The 2009 BRFSS response rate was 52.5%, 
resulting in a total sample size of 432,607 
27 & 28
.  Post-stratification weights are used to insure 
representative national population based estimates 
29
.   All data used in this study was taken from 
the core component file, and excluded responses from Puerto Rico, the U.S. Virgin Islands, and 
Guam. 
Study Sample 
 The cases of breast, prostate, and colorectal cancer survivors was identified through a 
series of questions in the 2009 BRFSS.  The Cancer Survivors section of the core module begins 
by asking, “Have you ever been told by a doctor, nurse, or other health professional that you had 
cancer?” Of those who answered “yes” to this question, they were then asked, “How many 
different types of cancer have you had?”  For purposes of this study, we only included survivors 
of one primary cancer.  Cancers of the breast, prostate, colon, and rectum were identified with 
the question, “What type of cancer was it?”  Colon and rectum were combined to form colorectal 
cancer.  Male survivors of breast cancer were excluded from the sample.  Only survivors age > 
18 years were included in the sample in order to comprise an adult sample.  The question, “At 
what age were you told that you had cancer?”, allowed for the calculation of time since diagnosis 
by subtracting the age at diagnosis from the currently reported age.  To avoid the competing 
interest of possible ongoing treatment, only breast, prostate, and colorectal survivors who were > 
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1 year post diagnosis were included in the study sample.  However, questions regarding the type 
of treatment received and stage at diagnosis were not asked, and therefore these covariates could 
not be controlled for in this study.  Finally, participants with missing information for any 
dependent variables were excluded from the sample.  The final case sample consisted of 6,393 
breast, 3,636 prostate, 1,111 female and 824 male colorectal cancer survivors. 
Measures 
Dependent Variables  
 Measures of HRQOL were assessed by the following survey questions: life satisfaction = 
“In general, how satisfied are you with your life?” (very satisfied, satisfied, dissatisfied, or very 
dissatisfied), perceived level of emotional support = “How often do you get the social and 
emotional support that you need?” (always, usually, sometimes, rarely, or never), presence of 
activity limitations  = “Are you limited in any way in any activities because of physical, mental, 
or emotional problems?” (yes or no), perceived general health status =  “Would you say that in 
general your health is:” (excellent, very good, good, or fair, poor).  Perceived physical  and 
mental health = “Now thinking about your physical health, which includes physical illness and 
injury, for how many days during the past 30 days was your physical health not good?” and 
“Now thinking about your mental health, which includes stress, depression, and problems with 
emotions, for how many days during the past 30 days was your mental health not good?” 
(number or days or none), and sleep quality = “How many days did you not get enough sleep in 
the past 30 days?”  (number of days or none).  For purposes of this study, responses to questions 
about physical health, mental health, and sleep quality were categorized as “none”, “1 – 15 
days”, and “> 15 days”.   
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Independent Variables  
 Environmental factors were metro status (metro or non-metro) where metro = in center 
city of an MSA, outside center city of an MSA, but inside the county containing the center city, 
and inside a suburban county of the MSA and non-metro = in an MSA that has no center city and 
not in an MSA; and region of the U.S. (Northeast, Midwest, West, and South) grouped by state 
according to defined U.S census regions [10A].  Measures of enabling factors included marital 
status (married, widowed, separated/divorced, and never married); employment status (employed 
or unemployed) where employed = employed for wages and self-employed and unemployed = 
out of work for more than 1 year, out of work for less than 1 year, homemaker, student, retired 
and unable to work; annual household income (< $25,000, $25,000 - $35,000, $35,000 - 
$50,000, $50,000 - $75,000, >$75,000, and missing/don’t know), insurance status (insured or 
uninsured), and have a usual source of care (yes or no).   
 Predisposing factor were age (18 - 49, 50 – 54, 55 – 59, 60 – 64, 65 – 69, 70 – 74, and > 
75 years), gender (male or female), race/ethnicity (White, African American, Latino, and Other), 
education (< high school, high school graduate, some college or technical school, and college or 
technical school graduate) and time since diagnosis calculated by subtracting the cancer 
survivor’s age at diagnosis from their current age.   
 Measures of need were considered to be the presence of specific health condition 
according to an affirmative response to ever being told so by a health professional.  Health 
condition are as follows: heart disease (answered yes to ever been told to have myocardial 
infarction, angina or coronary heart disease), hypertension (yes to every been told to have high 
blood pressure), high cholesterol (adults who had their blood cholesterol checked and told it was 
high), diabetes (yes to ever been told to have it, have it only during pregnancy, or borderline 
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diabetes),  stroke (yes to ever been told to have had a stroke), asthma (yes to ever been told to 
have asthma), and arthritis (yes to ever been told to arthritis).   
Analysis 
Propensity Score Matched Controls 
 Like the cancer cases, potential controls were selected if they were of age > 18 years and 
did not have missing responses for the dependent variables.  Logistic regression was used to 
derive a propensity score for each case and potential control based upon the probability of the 
individual having cancer and belonging to various categories of age, gender, race/ethnicity, 
income, insurance status, and region of the U.S.  Matching without replacement was performed 
using a greedy matching algorithm to assign three controls to every case.  A 3:1 control sample 
was used to control for the effects of any remaining bias.  After matching, Chi-square tests were 
performed to determine if balance was achieved on the covariates between the cases and 
controls.   
Statistical Methods 
 Descriptive statistics and Chi-square tests were performed to compare socio-demographic 
factors, health conditions, and measures of HRQOL between cases and controls.  Differences 
were determined to be significant for p values < .05.  The probabilities of reporting specific 
outcomes of HRQOL measures were compared between cases and controls using binary and 
multinomial logistic regression adjusting for selected covariates.  Specific covariates adjusted for 
in regression models were the presence of cancer (case vs. control comparisons only), 
race/ethnicity, age, marital status, metro status, region of the U.S., education, employment, 
income, health insurance, usual source of care, CVD-MS (Cardiovascular Disease - Metabolic 
Syndrome, includes the presence of heart disease, high cholesterol, hypertension, and or 
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diabetes), stroke, asthma, and arthritis. Regression models were stratified by time since diagnosis 
(1 – 5 years and > 5 years), preserving the propensity score matched control pairings for each 
group of survivors.  The same HRQOL comparisons were modeled between the types of cancers 
and genders, omitting the time since diagnosis stratifications.  Specific covariates adjusted for in 
regression models were the presence of cancer (case vs. control comparisons only), 
race/ethnicity, age, marital status, metro status, region of the U.S., education, employment, 
income, health insurance, usual source of care, CVD-MS (Cardiovascular Disease - Metabolic 
Syndrome, includes the presence of heart disease, high cholesterol, hypertension, and or 
diabetes), stroke, asthma, and arthritis.  HRQOL measures modeled using binary logistic 
regression were life satisfaction (very satisfied/satisfied) and activity limitations (yes).  
Multinomial logistic regression was used to model level of emotional support (rarely/never and 
sometimes), perceived general health status (fair/poor and good), perceived physical health (bad 
and medium), perceived mental health (bad and medium), and sleep quality (bad and medium).  
Reference categories are shown in parenthesis.  Parameter estimates calculated in the regression 
models were converted to odds ratios and corresponding 95% confidence intervals.   
 Data was weighted so that all estimates provided are nationally representative.  Post-
stratification weighs were applied to the data before the propensity score matching process.  All 
analysis were conducted using SAS version 9.2 software (SAS Institute Inc., Cary, NC), to 
account for the complex sample design. 
Results 
Description: Table 1 
 A comparison of demographic characteristics between adult survivors of breast, 
colorectal, and prostate cancers living > 1year post diagnosis who participated in the 2009 
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BRFSS to their propensity score matched controls is presented in Table 1.  While the age > 75 
years represented was the majority age group of breast (28.7%), female colorectal (39.5%), male 
colorectal (29.9%) and prostate (45.3%) cancer survivors. All cancer survivor groups were 
mostly white (78.6% - 83.3%), married (56.4% - 77.1%), unemployed (63.8% - 76.6%), insured 
(95.7% - 97.9%), reported a usual source of care (94.6% - 96.4%), residing in the South region 
of the U.S. (33.8% - 40.3%), and living in a metropolitan area (77.9% - 82.1%).  Survivors of 
breast, male colorectal and prostate cancer reported higher levels of education attainment, 
whereas the majority of female colorectal cancer survivors were only high school graduates.  The 
majority of prostate cancer survivors had an annual income > $75,000, while breast, female and 
male colorectal cancer survivors had an annual income < $25,000.      
 Balance was achieved between cancer survivors and their matched controls for all 
covariates modeled in the propensity score matching process.  Additionally, there was no 
difference between cancer survivors and their matched controls for metro status and marital 
status.  However, survivors of breast cancer were more frequently reported being a college or 
technical school graduate compared to their matched controls (36.5% vs. 32.1%) (p < .000) and 
prostate cancer survivors more frequently reported being unemployed compared to their matched 
controls (76.2% vs. 73.1%) (p = .049).  All cancer groups, with the exception of female 
colorectal, more frequently reported having a usual source of care (p < .000) compared to their 
matched controls.  
 A comparison of the prevalence of specific health conditions between cancer survivor 
and matched controls is shown in Table 2. Compared to their matched controls, survivors of 
breast cancer reported a greater prevalence of arthritis (52.9% vs. 48.4%) (p = .001), diabetes 
(17.8% vs. 15.9%) (p = .050), and high cholesterol (48.7% vs. 46.1%) (p = .001).  In similar 
28 
 
fashion, survivors of prostate cancer reported a greater prevalence of arthritis (47.8% vs. 41.5%) 
(p = .000), hypertension (58.2% vs. 53.7%) (p = .007), and high cholesterol (53.8% vs. 48.1%) 
(p < .000) compared to their matched controls.  Compared to their controls, male colorectal 
cancer survivors reported a greater prevalence of asthma (13.3% vs. 8.0%) (p = .003). 
Aim 1: Table 3 
 All cancer groups significantly differed from their matched controls with respect to 
activity limitations and perceived general health status.  In comparison to their matched controls, 
survivors of breast (30.6% vs. 25.6%) (p < .000), female colorectal (37.0% vs. 28.4%) (p = 
.003), male colorectal (39.4% vs. 23.9%) (p < .000), and prostate (29.3% vs. 25.2%) (p = .005) 
reported a greater prevalence of activity limitations.  However, when compared to their matched 
controls on perceived general health status, survivors of breast (41.7% vs. 52.8%) (p < .000), 
female colorectal (32.3% vs. 44.9%) (p < .000), male colorectal (31.8% vs. 48.5%) (p < .000), 
and prostate (38.1% vs. 46.1%) (p < .000) less frequently perceived their general health to be 
excellent/very good.  Male colorectal cancer survivors reported more bad physical health days 
compared to their matched controls (60.5% vs. 68.7%) (p = .004), while female colorectal cancer 
survivors reported more bad mental health days compared to their matched controls (67.2% vs. 
72. 6%) (p = .039).   Additionally, male colorectal cancer survivors less frequently reported 
being very satisfied/satisfied with their life compared to their matched controls (92.7% vs. 
95.9%) (p = .025), and prostate cancer survivors reported more days they did not get enough 
sleep than did their matched controls (55.8% vs. 59.4%) (p = .021).   
Aim 2: Table 4 
 Adjusted logistic regression models estimates of HRQOL stratified by time since 
diagnosis showed that every cancer type was more likely to perceive their general health status 
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as fair/poor or good as compared to excellent/very good than their matched controls for almost 
every each time stratification.  This was especially so at 1 – 5 years post diagnosis for survivors 
of breast (OR = 3.26, (95%CI: 2.43 – 4.37), female colorectal (OR = 3.51, 95%CI: 2.09 – 5.92), 
and male colorectal cancer (OR = 3.67, 95%CI: 2.09 – 6.47) who were more than 3 times as 
likely to perceive their general health as fair/poor as compared to their matched controls, and 
survivors of prostate cancer were 1.72 times as likely (95%CI: 1.26 – 2.35) to perceive their 
general health as fair/poor as compared to excellent/very good than their matched controls.  
Likewise, at 1 – 5 years post diagnosis, survivors of breast (OR = 2.42, 95%CI: 1.91 – 3.06), 
female colorectal (OR = 2.04, 95%CI: 1.19 = 3.49), male colorectal (OR = 1.81, 95%CI: 1.05 – 
3.13), and prostate cancer (OR = 1.52, 95%CI: 1.17 – 1.97) were more likely to perceive their 
general health as good as compared to excellent/very good than their matched controls.  
Continuing this trend at > 5 years post diagnosis, survivors of breast (OR = 1.38, 95%CI: 1.15 – 
1.65), female colorectal (OR = 1.91, 95%CI: 1.30 – 2.79), and male colorectal (OR = 1.91, 
95%CI: 1.26 – 2.90) were still more likely to perceive their general health as fair/poor as 
compared to excellent that their matched controls.  Survivors of breast (OR = 1.44, 95%CI: 1.23 
– 1.68), male colorectal (OR = 2.24, 95%CI: 1.59 – 3.17), and prostate cancer (OR = 1.27, 
95%CI: 1.05 – 1.54) were also more likely to perceive their general health as good as compared 
to excellent/very good than their matched controls during this time period.   
 Activity limitations at 1 – 5 years post diagnosis were more likely to be reported by 
survivors of breast (OR = 1.41, 95%CI: 1.11 – 1.80), female colorectal (OR = 2.25, 95%CI: 1.45 
– 3.51), male colorectal (OR = 2.62, 95%CI: 1.72 – 3.99) as compared to their matched controls.  
Survivors of breast (OR = 1.18, 95%CI: 1.04 – 1.35) and male colorectal (OR = 1.70, 95%CI: 
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1.23 – 2.36) were still more likely to report activity limitations at > 5 years post diagnosis than 
their matched controls.   
 While all groups of survivors perceived their general health to be less than excellent/very 
good at both time stratification and survivors of breast, female and male colorectal were also 
more likely to report activity limitations as compared to their matched controls, cancer survivors 
did not distinguish as much on measures of perceived physical and mental health.  Only female 
colorectal cancer survivors were 1.64 times more likely (95%CI: 1.06 – 2.54) to perceive their 
physical health as bad 1 – 15 days vs. none in the past month as compared to their matched 
controls at 1 – 5 years post diagnosis, and male colorectal cancer survivors were 1.77 times more 
likely (95%CI: 1.23 – 2.55) to perceive their physical health as bad 1 – 15 days vs. none as 
compared to their matched controls as > 5 years post diagnosis.  Male colorectal cancer survivors 
were 2.00 times more likely (95%CI: 1.17 – 3.42) to perceive their mental health as bad 1 – 15 
days vs. none in the past month as compared to their matched controls at 1 – 5 years post 
diagnosis.  Prostate cancer survivors were 1.40 times more likely (95%CI: 1.01 – 1.93) to 
perceive their mental health as bad 1 – 15 days vs. none in the past month as compared to their 
matched controls at 1 – 5 years post diagnosis.  Moreover, prostate cancer survivors were 1.48 
times more likely (95%CI: 1.01 – 2.16) at 1 – 5 years post diagnosis and 1.78 times more likely 
(95%CI: 1.08 – 2.95) to report rarely/never or only sometimes vs. always/usually receiving 
needed emotional support as compared to their matched controls.   Prostate cancer survivors 
were also 1.61 times more likely (95%CI: 1.13 – 2.29) at 1 – 5 years post diagnosis to report > 
15 days of not enough sleep vs. none in the past month as compared to their matched controls.   
 With regards to life satisfaction, female colorectal cancer survivors were 3.32 times more 
likely (95%CI: 1.21 – 9.13) at 1 – 5 years post diagnosis to be very satisfied/satisfied vs. very 
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dissatisfied/ dissatisfied with their life than their matched controls.  However, male colorectal 
cancer survivors were 0.33 times less likely (95%CI: 0.17 – 0.65) at > 5 years post diagnosis to 
be very satisfied/satisfied vs. very dissatisfied/ dissatisfied with their life as compared to their 
matched controls.  
Aim 3: Table 5 
 Between females, breast cancer survivors were 0.68 times less likely (95%CI: 0.50 – 
0.93) to perceive their general health as fair/poor as compared to excellent/very good than female 
colorectal cancer survivors.  Between males, prostate cancer survivors were 0.63 times less likely 
(95%CI: 0.45 – 0.88) to perceive their general health as fair/poor as compared to excellent/very 
good, 0.70 times less likely (95%CI: 051 – 0.95) to perceive their physical health as bad 1 – 15 
days vs. none in the past month, and 0.61 times less likely (95%CI: 0.45 – 0.83) to report activity 
limitations than male colorectal cancer survivors.   
 Comparing females and males in the gender-neutral cancer (colorectal), female colorectal 
cancer survivors were 0.67 times less likely (95%CI: 0.45 – 0.98) to perceived their general 
health as good as compared to excellent/very good, 0.63 times less likely (95%CI: 0.45 – 0.87) to 
report activity limitations, and 2.20 times more likely to be very satisfied/satisfied with their life 
compared to male colorectal cancer survivors.  However, female colorectal cancer survivors 
were 1.86 times more likely (95%CI: 1.16 – 2.98) to perceive their mental health as bad 1 – 15 
days vs. none mental health in the past month, 3.17 times more likely (95% CI: 1.76 – 5.71) to 
report rarely/never vs. always/usually receiving needed emotional support, and 1.53 times more 
likely to report not getting enough sleep 1 – 15 days vs. none in the past month compared to male 
colorectal cancer survivors.  Comparisons of women and men between gender-specific cancers 
(breast and prostate) found that breast cancer survivors were 1.35 times more likely (95%CI: 
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1.13 – 1.63) and 1.58 times more likely (95%CI: 1.28 – 1.94) to perceive their physical and 
mental health as bad 1 – 15 days vs. none in the past month compared to prostate cancer 
survivors.  Breast cancer survivors were also 2.12 (95%CI: 1.58 – 2.84) and 1.56 (95%CI: 1.08 – 
2.24) times more likely to report rarely/never and sometimes vs. always/usually receiving needed 
emotional support and were 1.33 (95%CI: 1.04 – 1.70) and 1.49 (95%CI: 1.26 – 1.77) times 
more likely to report not getting enough sleep > 15 days and 1 – 15 days vs. none in the past 
month compared to prostate cancer survivors.   
Discussion 
 It has been well documented that survivors of breast, prostate and colorectal cancer often 
continue to experience a diminished HRQOL over the course of a lifetime due to the late and 
long lasting symptoms and effects of cancer and its treatment, but little research has studied how 
the measures of HRQOL may differ from those without a history of cancer in their cohort, or 
from one another by type of cancer and gender.  This is the first study to compare these survivors 
to groups of controls stringently matched for each cancer type in order to minimize bias and 
capture the unique experience that having had cancer has upon multiple measures of HRQOL.  
Furthermore, this is the first study these authors know of to compare these HRQOL measures 
between cancer type and gender it order to provide a better understanding as to how these 
differences may be associated with variations in HRQOL.    
 Compared to their matched controls survivors of breast, female colorectal, male 
colorectal, and prostate cancer at 1 – 5 years and > 5 years post diagnosis were all more likely to 
perceive their general health as only fair/poor and good vs. excellent/very good.  Additionally, 
breast, female colorectal, and male colorectal cancer survivors at 1 – 5 years post diagnosis and 
breast and male colorectal cancer survivor at > 5 years post diagnosis were more likely to report 
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activity limitations than their matched controls.  However, cancer survivors did differentiate 
from their controls as much on their perceptions of physical and mental health.  Only female 
colorectal cancer survivors at 1 – 5 years post diagnosis, and male colorectal cancer survivors at 
> 5 years post diagnosis, perceived themselves to have more bad physical health days, and only 
male colorectal and prostate cancer survivors, at 1 – 5 years post diagnosis, perceived themselves 
to have more bad mental health days in the past month as compared to their matched controls.  
Moreover, male colorectal cancer survivors at > 5 post diagnosis were more likely to report low 
levels of life satisfaction, and prostate cancer survivors at 1 – 5 years post diagnosis were more 
likely to report not getting enough sleep, compared to their matched controls.   
 While the current study findings concerning perceptions of general health and activity 
limitations between these survivor groups and controls are in agreement with previous research, 
the current finding regarding perception of physical and mental health are contrast to previous 
study findings of mental health between these cancer survivor types.  Yabroff and colleagues 
(2004) found that survivors of breast, colorectal, and prostate cancer reported their general health 
to be fair/poor and good vs. excellent/very good and the presence of activity of limitations with 
greater frequency than did a single group of controls matched for age, gender, and education 
20
.  
Eakin and colleagues (2006) also found that an Australian sample of breast, and colorectal 
cancer survivors 65 years and older, > 5 years post diagnosis were more likely to perceive their 
general health as fair/poor and good vs. excellent as compared to a single group of controls 
matched for age and gender 
21
.  However, current study findings pertaining to perceived physical 
and mental health status are more difficult to compare to those of previous research.  A study by 
Smith and colleagues (2008) used a large national survey of Medicare beneficiaries to compare 
physical component summary scores of breast, prostate, and colorectal cancer survivors to those 
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without a history of cancer.  They found small, but significant differences, indicating physical 
health to be slightly worse among all three survivors groups compared to those without a history 
of cancer 
23
.  Similarly, a comparison of mental health component summary scores also showed 
small, but significantly worse outcomes among breast and colorectal cancer survivors as 
compared to those without a history of cancer.  Eakin and colleagues (2006) found only 
colorectal cancer survivors to be more likely to have worse mental health scores compared to age 
and gender matched controls 
21
.  All studies found worse physical health outcomes among 
colorectal cancer survivors, but this study did not also observe worse physical health among 
survivors of breast and prostate cancer in comparison to matched controls as was the finding by 
Smith and colleagues (2008) 
23
.  This differential finding may be explained by sample 
characteristics and study design.  The data selected for analysis in the study by Smith and 
colleagues was limited to individuals age > 65 years and older and the comparison group was not 
matched to the cancer survivors on any measure, and survivors of breast, prostate and colorectal 
cancers were found to have a significantly greater number of comorbid conditions than those 
without a history of cancer.  The older age group, lacking of matching, and increased 
comorbidity may explain physical health outcomes observed among all three survivor groups in 
that study.    
 HRQOL comparisons between cancer types found that breast cancer survivors were less 
likely to perceive their general health as fair/poor than were female colorectal cancer survivors.  
Likewise, prostate cancer survivors were less likely to perceive their general health to be 
fair/poor, and perceive more bad physical health days, or report activity limitations as compared 
to male colorectal cancer survivors.  The increase in activity limitations and poorer health 
perceptions among colorectal cancer survivors are most likely attributable to the large 
35 
 
proportion, 45% - 71%, of rectal cancer patients who undergo nonrestorative proctectomy 
surgery, resulting in the presence of a stoma 
30
.  Colorectal and rectal patients with stomas report 
greater limitations and physical problems compared to those without a permanent stoma 
22 & 31
 .   
 Comparisons between genders revealed differences in HRQOL extending beyond activity 
limitations and general and physical health perceptions.  Compared to male colorectal cancer 
survivors, females were less likely to report activity limitations and perceptions of worse general, 
however, females were more likely to report not getting enough sleep, not receiving adequate 
emotional support, as well a greater number of perceived bad mental health days.  Yet, female 
colorectal cancer survivors were almost three times as likely to report being very satisfied/ 
satisfied with their life in comparison to male colorectal cancer survivors.  Differences in 
HRQOL outcomes between breast cancer survivors and prostate cancer survivors showed a 
similar pattern.  Breast cancer survivors were more likely to report not getting enough sleep, not 
receiving adequate emotional support, and a greater number of bad mental health days.  
Additionally, survivors of breast cancer were also more likely to report a greater number of bad 
physical health days than survivors of prostate cancer.  While cancer type cannot be controlled 
for when comparing breast and prostate cancer survivors, the pattern of HRQOL differences are 
similar enough to those observed between female and male colorectal cancer survivors to suggest 
that the differences are a function of gender.  In both gender comparisons, women were more 
likely to report worse outcomes related to sleep quality, emotional support and mental health.  
Sleep disturbances, insomnia, and fatigue among cancer survivors have been associated with 
poorer health perceptions, psychosocial outcomes, and increased depression and anxiety 
14 & 32
.  
Furthermore, female cancer survivors have been found to be more likely to experience insomnia, 
depression and anxiety than males 
14 & 33
.  A recent study by Deshields and colleagues (2011) 
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comparing symptom experience between different types of cancer survivors observed that breast 
(59%) and colorectal (71%) experienced a greater difficulty sleeping than prostate cancer 
survivors (39%).  Breast (50%) and colorectal cancer survivors (47%) also reported a greater 
prevalence of feeling sad than prostate cancer survivors (24%) 
19
.  A qualitative study comparing 
gender differences in HRQOL between long-term female and male colorectal cancer survivors 
with ostomies found that women were more likely to discuss difficulties with sleep and 
depression than men 
31
.   
 Despite worse HRQOL outcomes regarding psychological and emotional well-being, 
female cancer survivors, especially, female colorectal, were less likely to report activity 
limitations and a worse perceived general health than their male comparisons.  Studies of 
physical activity have shown that men tend to be more physical active than women 
34 & 35
.  
Therefore if baseline levels of physical activity prior to cancer had been higher among men than 
women, men who have a stoma, or who have had surgery on the lower half of their bodies, may 
feel that they are more limited and that their general health has been compromised, as compared 
to those who were not as active prior to cancer.  This may also explain why female colorectal 
cancer survivors reported greater life satisfaction than their male counterparts.   
 This study was conducted using a large sample of data from a recent national survey.  
Cancer survivors sampled represented a diverse range in age and time since diagnosis.  The 
method of propensity score matching was used to matching cases to controls in order to provide 
rigorous control of confounding bias.  This study compared a variety of HRQOL measures that 
encompassed the physical, mental, emotional domains, as well as functional and symptomatic 
outcomes such as activity limitations and sleep disturbances.  These measures were compared to 
matched controls for each cancer type and between cancer types and genders.  Moreover, this 
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study was also able to examine differences in both short and long-term survivors in comparison 
to matched controls.  However, this comparison of short and long-term survivors was not able to 
be conducted in a longitudinal nature, but rather by division of point-in-time measures among a 
cross-sectional sample.  The current study was conducted using self-reported data that may 
contain responder bias.  Furthermore, stage at diagnosis and type of treatment received, both of 
which are known to be associated with HRQOL outcomes, were not assessed in the survey. 
Finally, the HRQOL of survivors who have died could not be included in the study.  It remains 
unknown if they would have had a worse HRQOL due to a later stage of diagnosis or if they died 
of non-cancer related mortality and there HRQOL would have been similar to the study sample.  
Conclusions 
 The current study has shown that survivors of breast, female colorectal, male colorectal, 
and prostate cancers experience a diminished HRQOL throughout the survivorship continuum in 
comparison to similar individuals without a history of cancer.  All cancer survivor types reported 
more activity limitations and poorer perceptions of general health compared to controls.  
Additional HRQOL outcomes that differed from controls and the magnitude of their severity 
varied according to cancer type.  Some differences were observed between cancer types, with 
male colorectal cancer survivors reporting poorer general and physical health and more activity 
limitations that prostate cancer survivors, most likely attributable to treatment.  However, 
numerous differences emerged between men and women.  Female colorectal cancer survivors 
experienced less activity limitations and poor perceptions of general health than did male 
colorectal cancer survivors, and a similar trend was observed between breast and prostate cancer 
survivors.  Yet, both female cancer survivor groups reported less sleep, poorer mental health, and 
less emotional support than the male cancer survivors.  These findings suggest that physical and 
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activity domains of HRQOL among male cancer survivors is more vulnerable to be negatively 
affected after cancer, while the psychological well-being of female cancer survivors is at a 
greater risk for decline.  As the population of cancer survivors grow due to increasing survival 
rates, so will the need for monitoring and treatment of the late and long lasting symptoms and 
their effects upon HRQOL after primary cancer treatment.  Whether cancer survivors receive 
follow-up care from oncology specialists or primary care physicians, it is important that all 
health care providers recognize the decrements in HRQOL experienced by cancer survivors in 
comparison to those who have not had cancer.  Moreover, it may be equally important to 
recognize the ways in which cancer survivors may differ from one another with respect to cancer 
type and/or gender in order to provide care according to the unique needs of each individual.    
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Table 1. 
Description of Cancer Survivors and Non-Cancer Controls 
Behavioral Risk Factor Surveillance System, 2009 
  
 
BC  BC Controls Sig. CC  (Female) CC Controls Sig. CC (Male) CC Controls Sig. PC  PC Controls Sig. 
  
 
N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value 
All 6393 25.0 19179 75.0   1111 25.0 3333 75.0   824 25.0 2472 75.0   3636 25.0 10908 75.0   
Region of the U.S.   
   
0.406 
    
0.954 
    
0.921 
    
0.170 
  Northeast 1235 22.0 3710 20.4   198 21.0 594 20.1   153 16.4 454 17.7   615 19.6 1861 18.0   
  Midwest 1609 24.1 4825 23.8   319 25.2 953 24.5   213 24.3 632 23.7   893 23.4 2670 22.4   
  South 1972 33.8 5926 34.3   373 36.9 1125 37.4   271 40.3 818 39.0   1156 36.2 3522 39.8   
  West 1577 20.1 4718 21.5   221 16.8 661 18.0   187 19.0 568 19.5   972 20.8 2855 19.9   
Metro Status   
   
0.067 
    
0.300 
    
0.893 
    
0.274 
  Metro 4264 82.1 12525 80.5   693 77.9 2099 80.2   516 79.1 1570 79.4   2368 81.0 7119 79.8   
  Non-Metro 2106 17.9 6562 19.5   414 22.1 1216 19.8   303 20.9 893 20.6   1253 19.0 3739 20.2   
Gender   
   
1.000 
    
1.000 
    
1.000 
    
1.000 
  Female 6393 100.0 19179 100.0   1111 100.0 3333 100.0   0 0.0 0 0.0   0.0 0.0 0.0 0.0   
  Male 0 0.0 0 0.0   0 0.0 0 0.0   824 100.0 2472 100.0   3636 100.0 10908 100.0   
Race/Ethnicity   
   
0.280 
    
0.281 
    
0.456 
    
0.561 
  White 5559 80.6 16681 81.6   971 83.3 2913 80.3   704 80.7 2116 79.8   3057 78.6 9203 77.7   
  AA 407 9.9 1226 7.9   78 10.5 231 8.8   53 10.2 154 8.2   355 12.4 1039 13.3   
  Latino 163 5.2 483 5.4   26 2.1 79 5.2   33 6.3 97 7.9   93 5.5 277 4.6   
  Other 264 4.3 789 5.1   36 4.2 110 5.6   34 2.8 105 4.0   131 3.6 389 4.4   
Age   
   
0.426 
    
0.967 
    
0.936 
    
0.151 
  18 - 49 390 10.2 1170 12.0   40 6.8 120 8.0   36 8.8 108 10.9   18 1.1 54 2.6   
  50 - 54 477 10.6 1432 10.0   57 8.2 170 8.6   37 6.5 111 6.8   63 3.4 189 2.7   
  55 - 59 703 12.2 2119 11.7   90 7.8 270 8.6   75 10.4 225 9.3   171 5.8 516 6.3   
  60 - 64 906 13.0 2716 13.7   114 10.6 342 10.4   115 14.9 347 14.6   412 13.2 1240 13.2   
  65 - 69 989 13.4 2959 13.2   129 10.4 388 9.2   141 15.8 425 16.4   602 13.3 1815 14.8   
  70 - 74 938 11.9 2820 12.2   190 16.7 570 15.0   126 13.7 377 12.7   735 17.8 2175 18.3   
  > 75 1990 28.7 5963 27.2   491 39.5 1473 40.1   294 29.9 879 29.4   1635 45.3 4919 42.0   
Marital Status   
   
0.107 
    
0.296 
    
0.401 
    
0.192 
  Married 3019 59.4 9174 58.9   442 56.4 1321 52.0   524 75.0 1614 75.3   2501 77.1 7263 75.8   
  Widowed 1978 22.3 6169 22.8   446 26.8 1362 30.9   142 11.1 377 8.9   561 10.6 1877 11.6   
  Sep/Divorced 1030 13.4 2813 12.1   178 13.4 501 13.0   107 9.4 334 10.8   405 9.1 1228 8.3   
  Never Married 366 4.9 1023 6.2   45 3.4 149 4.1   51 4.4 147 5.0   169 3.3 540 4.3   
Education   
   
0.000*** 
    
0.367 
    
0.114 
    
0.606 
  < HS 445 6.4 1762 8.8   142 15.2 415 13.9   99 11.7 287 11.4   385 9.7 1235 10.5   
  HS Grad 2008 29.6 6537 31.9   414 36.4 1256 33.6   264 30.5 747 28.8   979 25.4 3151 26.7   
  Some Col/TS 1832 27.5 5297 27.2   324 26.6 836 25.6   193 25.5 557 21.0   795 22.7 2382 22.5   
  Col/TS Grad 2108 36.5 5583 32.1   231 21.9 826 26.9   268 32.3 881 38.9   1477 42.1 4140 40.3   
Abbreviations: BC, Breast Cancer; CC, Colorectal Cancer; PC, Prostate Cancer; AA, African American; Sep, Separated; HS, High School; Grad, Graduate; Col, College  TS, Technical School; DK, 
Don't Know;   
    Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
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Table 1. 
Description of Cancer Survivors and Non-Cancer Controls 
Behavioral Risk Factor Surveillance System, 2009 
  
 
BC  BC Controls Sig. CC  (Female) CC Controls Sig. CC (Male) CC Controls Sig. PC  PC Controls Sig. 
  
 
N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value 
All 6393 25.0 19179 75.0   1111 25.0 3333 75.0   824 25.0 2472 75.0   3636 25.0 10908 75.0   
Employment Status   
   
0.062 
    
0.332 
    
0.822 
    
0.049 * 
  Employed  1935 33.1 6054 35.5   216 23.9 747 26.8   248 36.2 736 36.9   795 23.8 2662 26.9   
  Unemployed 4458 66.9 13125 64.5   895 76.1 2586 73.2   576 63.8 1736 63.1   2841 76.2 8246 73.1   
Family Income   
   
0.191 
    
0.585 
    
0.433 
    
0.993 
  < $25,000 1884 24.9 5658 24.6   442 31.9 1331 34.6   245 26.2 738 28.3   798 19.5 2383 19.7   
  $25,000 - $35,000 849 10.9 2545 12.1   150 12.2 454 13.1   114 13.4 342 11.7   501 12.1 1492 11.6   
  $35,000 - $50,000 932 14.6 2788 14.6   136 12.5 402 12.2   124 14.7 370 12.8   641 17.5 1934 17.2   
  $50,000 - $75,000 758 12.0 2267 13.1   96 12.6 288 10.6   112 16.8 336 14.2   575 15.7 1694 15.5   
  > $75,000 1084 22.8 3253 22.8   117 13.5 348 15.3   158 22.1 476 25.7   776 25.0 2312 25.8   
  Missing/DK 886 14.8 2668 12.7   170 17.3 510 14.2   71 6.9 210 7.3   345 10.2 1093 10.2   
Insurance Status   
   
0.769 
    
0.893 
    
0.707 
    
0.790 
  Insured 6156 95.8 18482 96.0   1076 95.7 3221 95.9   789 96.0 2374 95.5   3557 97.9 10697 98.0   
  Uninsured 237 4.2 697 4.0   35 4.3 112 4.1   35 4.0 98 4.5   79 2.1 211 2.0   
Usual Source of Care   
   
0.000*** 
    
0.651 
    
0.000*** 
    
0.000*** 
  Yes 6151 96.0 18007 93.2   1078 94.9 3169 94.0   776 94.6 2238 89.2   3498 96.4 10099 93.2   
  No 236 4.0 1149 6.8   33 5.1 157 6.0   48 5.4 231 10.8   132 3.6 795 6.8   
Abbreviations: BC, Breast Cancer; CC, Colorectal Cancer; PC, Prostate Cancer; AA, African American; Sep, Separated; HS, High School; Grad, Graduate; Col, College      
    TS, Technical School; DK, Don't Know; 
              Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
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Table 2. 
Comparison of Chronic and Comorbid Health Conditions between Cancer Survivors and Non-Cancer Controls 
Behavioral Risk Factor Surveillance System, 2009 
  
 
BC  BC Controls Sig. CC  (Female) CC Controls Sig. CC (Male) CC Controls Sig. PC  PC Controls Sig. 
  
 
N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value 
All 6393 25.0 19179 75.0   1111 25.0 3333 75.0   824 25.0 2472 75.0   3636 25.0 10908 75.0   
Arthritis   
   
0.001** 
    
0.083 
    
0.068 
    
0.000*** 
  Yes 3591 52.9 10003 48.4   665 60.6 1873 55.0   353 46.3 1061 41.0   1815 47.8 4714 41.5   
  No 2788 47.1 9121 51.6   442 39.4 1447 45.0   469 53.7 1404 59.0   1814 52.2 6133 58.5   
Asthma   
   
0.568 
    
0.947 
    
0.003** 
    
0.637 
  Yes 832 13.4 2477 13.9   148 12.5 384 12.4   94 13.3 214 8.0   366 9.5 916 9.0   
  No 5542 86.6 16656 86.1   958 87.5 2941 87.6   728 86.7 2253 92.0   3263 90.5 9954 91.0   
Heart Disease   
   
0.260 
    
0.580 
    
0.538 
    
0.093 
  Yes 670 8.9 2029 9.7   158 12.7 425 11.7   177 18.9 578 20.2   780 20.1 2524 22.3   
  No  5657 91.1 16954 90.3   944 87.3 2861 88.3   640 81.1 1864 79.8   2807 79.9 8260 77.7   
Diabetes   
   
0.050* 
    
0.445 
    
0.184 
    
0.722 
  Yes 1144 17.8 3121 15.9   246 18.8 639 20.5   216 25.1 579 21.8   814 23.6 2517 23.1   
  No 5245 82.2 16049 84.1   865 81.2 2693 79.5   606 74.9 1889 78.2   2819 76.4 8380 76.9   
Hypertension   
   
0.779 
    
0.301 
    
0.096 
    
0.007** 
  Yes 3268 46.4 9730 46.8   636 56.7 1877 53.4   455 53.1 1313 48.3   2194 58.2 6065 53.7   
  No 3118 53.6 9412 53.2   473 43.3 1444 46.6   368 46.9 1150 51.7   1439 41.8 4819 46.3   
High Cholesterol   
   
0.001** 
    
0.399 
    
0.913 
    
0.000*** 
  Yes 3246 48.7 9318 46.1   554 47.0 1692 48.3   390 49.3 1220 48.8   1982 53.8 5321 48.1   
  No 2957 48.0 8957 48.2   519 49.5 1492 46.6   397 46.4 1142 46.3   1562 43.7 5118 47.2   
  No Test 190 3.4 904 5.7   38 3.5 149 5.1   37 4.3 110 4.8   92 2.5 469 4.7   
Stroke   
   
0.497 
    
0.512 
    
0.694 
    
0.870 
  Yes 327 4.7 1051 5.0   90 8.0 206 6.7   56 6.4 190 6.9   266 6.9 814 6.7   
  No 6047 95.3 18077 95.0   1018 92.0 3113 93.3   765 93.6 2277 93.1   3358 93.1 10064 93.3   
Abbreviations: BC, Breast Cancer; CC, Colorectal Cancer; PC, Prostate Cancer; AA, African American; Sep, Separated; HS, High School; Grad, Graduate; Col, College      
    TS, Technical School; DK, Don't Know; 
              Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
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Table 3. 
Comparison of Health Related Quality of Life of Cancer Survivors and Non-Cancer Controls 
Behavioral Risk Factor Surveillance System, 2009 
  
 
BC BC Controls Sig. CC (Female) CC Controls Sig. CC (Male) CC Controls Sig. PC PC Controls Sig. 
  
 
N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value 
All 6393 25.0 19179 75.0 
 
1111 25.0 3333 75.0 
 
824 25.0 2472 75.0 
 
3636 25.0 10908 75.0 
 Life Satisfaction 
    
0.221 
    
0.608 
    
0.025* 
    
0.377 
  Very Satisfied/Satisfied 5713 94.8 17147 95.5 
 
968 95.9 2949 95.3 
 
717 92.7 2188 95.9 
 
3239 96.5 9783 97.0 
   Dissat/Very Dissat 299 5.2 825 4.5 
 
45 4.1 141 4.7 
 
32 7.3 106 4.1 
 
141 3.5 317 3.0 
 Receive Needed  
    
0.413 
    
0.280 
    
0.085 
    
0.196 
Emotional Support 
                      Always/Usually 353 6.0 1228 6.8 
 
73 6.2 237 8.4 
 
87 12.7 253 10.7 
 
404 10.2 1264 11.9 
   Sometimes 725 11.7 2190 12.3 
 
137 13.8 411 12.1 
 
111 16.2 304 12.1 
 
411 12.8 1173 11.5 
   Rarely/Never 4934 82.3 14554 80.9 
 
803 80.0 2442 79.5 
 
551 71.0 1737 77.2 
 
2565 77.0 7663 76.6 
 Activity Limitations 
    
0.000*** 
    
0.004** 
    
0.000*** 
    
0.005** 
  Yes 2043 30.6 5401 25.6 
 
389 37.0 1011 28.4 
 
296 39.4 720 23.9 
 
1117 29.3 2972 25.2 
   No 4328 69.4 13702 74.4 
 
716 63.0 2305 71.6 
 
524 60.6 1742 76.1 
 
2505 70.7 7896 74.8 
 Perceived General Health 
    
0.000*** 
    
0.000*** 
    
0.000*** 
    
0.000*** 
  Excellent/Very Good 2426 41.7 8976 52.8 
 
333 32.3 1364 44.9 
 
243 31.8 1038 48.5 
 
1260 38.1 4534 46.1 
   Good 2162 36.5 5531 29.1 
 
351 32.9 990 31.7 
 
266 39.5 700 30.4 
 
1238 38.9 3419 33.8 
   Fair/Poor 1424 21.8 3465 18.1 
 
329 34.8 736 23.3 
 
240 28.7 556 21.2 
 
882 23.1 2147 20.2 
 Days Perceived  Physical 
Health Bad in Past Month 
    
0.146 
    
0.133 
    
0.004** 
    
0.712 
  None 3505 59.4 11229 62.0 
 
546 52.1 1858 58.3 
 
461 60.5 1529 68.7 
 
2205 67.0 6931 68.3 
   1-15 Days 1746 28.7 4697 27.2 
 
298 32.6 835 28.7 
 
184 28.2 474 20.1 
 
781 22.4 2113 21.4 
   15 < Days 761 11.9 2046 10.8 
 
169 15.3 397 13.0 
 
104 11.3 291 11.2 
 
394 10.6 1056 10.3 
 Days Perceived Mental 
Health Bad in Past Month 
    
0.550 
    
0.039* 
    
0.368 
    
0.118 
  None 4248 69.9 13061 70.0 
 
734 67.2 2299 72.6 
 
609 79.5 1885 82.0 
 
2813 82.9 8624 85.2 
   1-15 Days 1367 23.5 3855 24.2 
 
210 24.5 644 23.0 
 
103 15.8 291 12.9 
 
438 13.5 1103 11.2 
   15 < Days 397 6.5 1056 5.9 
 
69 8.3 147 4.4 
 
37 4.7 118 5.1 
 
129 3.6 373 3.6 
 Days Did Not Get Enough 
Sleep in Past Month 
    
0.844 
    
0.170 
    
0.367 
    
0.021* 
  None 2594 41.0 7941 40.6 
 
469 41.0 1505 46.7 
 
397 50.7 1234 51.6 
 
1908 55.8 6049 59.4 
   1-15 Days 2540 43.5 7710 44.3 
 
379 42.3 1206 39.4 
 
245 34.8 779 36.6 
 
1116 33.4 3202 32.1 
   15 < Days 878 15.5 2321 15.1 
 
165 16.7 379 13.9 
 
107 14.6 281 11.7 
 
356 10.8 849 8.4 
 Abbreviations: BC, Breast Cancer; CC, Colorectal Cancer; PC, Prostate Cancer; Dissat, Dissatisfied;                        
Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
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Table 4. 
Logistic Regression of the Health Related Quality of Life of Cancer Survivors to Non-Cancer Controls By Time Since Diagnosis 
Behavioral Risk Factor Surveillance System, 2009 
    Breast Cancer Colorectal Cancer (Female) Colorectal Cancer (Male) Prostate Cancer 
    AOR 95% CI Sig. AOR 95% CI Sig. AOR 95% CI Sig. AOR 95% CI Sig. 
Life Satisfaction   
  
    
 
    
 
    
 
  
Very Satisfied/Satisfied 1 - 5 Years 0.89 [0.58,1.36]   3.32 [1.21,9.13] * 1.78 [0.62,5.10]   0.96 [0.54,1.73]   
  5 < Years 0.96 [0.71,1.28]   0.62 [0.36,1.04]   0.33 [0.17,0.65] ** 0.97 [0.65,1.46]   
Receive Needed Emotional Support   
 
    
 
    
 
    
 
  
Rarely/Never 1 - 5 Years 0.89 [0.57,1.38]   1.41 [0.69,2.87]   0.93 [0.45,1.95]   1.48 [1.01,2.16] * 
  5 < Years 1.21 [0.91,1.60]   1.10 [0.67,1.81]   0.70 [0.41,1.20]   1.01 [0.79,1.28]   
Sometimes 1 - 5 Years 0.69 [0.42,1.13]   1.15 [0.49,2.71]   1.20 [0.52,2.76]   1.78 [1.08,2.95] * 
  5 < Years 1.17 [0.84,1.61]   1.22 [0.68,2.18]   0.99 [0.53,1.85]   0.98 [0.71,1.35]   
Activity Limitations   
 
    
 
    
 
    
 
  
Yes 1 - 5 Years 1.41 [1.11,1.80] ** 2.25 [1.45,3.51] *** 2.62 [1.72,3.99] *** 1.09 [0.83,1.43]   
  5 < Years 1.18 [1.04,1.35] * 1.23 [0.89,1.70]   1.70 [1.23,2.36] ** 1.17 [0.97,1.40]   
Perceived General Health   
 
    
 
    
 
    
 
  
Fair/Poor 1 - 5 Years 3.26 [2.43,4.37] *** 3.51 [2.09,5.91] *** 3.67 [2.09,6.47] *** 1.72 [1.26,2.35] *** 
  5 < Years 1.38 [1.15,1.65] *** 1.91 [1.30,2.79] *** 1.91 [1.26,2.90] ** 1.21 [0.96,1.53]   
Good 1 - 5 Years 2.42 [1.91,3.06] *** 2.04 [1.19,3.49] ** 1.81 [1.05,3.13] * 1.52 [1.17,1.97] ** 
  5 < Years 1.44 [1.23,1.68] *** 1.25 [0.89,1.76]   2.24 [1.59,3.17] *** 1.27 [1.05,1.54] * 
Days Perceived Physical Health    
 
    
 
    
 
    
 
  
Bad in Past Month   
 
    
 
    
 
    
 
  
15 < Days 1 - 5 Years 1.31 [0.94,1.83]   1.05 [0.58,1.90]   1.57 [0.85,2.91]   0.95 [0.63,1.44]   
  5 < Years 1.09 [0.90,1.32]   1.36 [0.91,2.04]   1.00 [0.63,1.60]   1.00 [0.77,1.31]   
1-15 Days 1 - 5 Years 1.17 [0.93,1.46]   1.64 [1.06,2.54] * 1.56 [0.95,2.55]   0.97 [0.75,1.25]   
  5 < Years 1.05 [0.90,1.22]   1.21 [0.87,1.70]   1.77 [1.23,2.55] ** 1.06 [0.86,1.30]   
Days Perceived Mental Health    
 
    
 
    
 
    
 
  
Bad in Past Month   
 
    
 
    
 
    
 
  
15 < Days 1 - 5 Years 1.18 [0.75,1.85]   0.91 [0.44,1.89]   1.06 [0.55,2.05]   1.41 [0.79,2.52]   
  5 < Years 1.03 [0.80,1.34]   1.58 [0.92,2.70]   1.27 [0.62,2.60]   0.68 [0.44,1.03]   
1-15 Days 1 - 5 Years 1.00 [0.79,1.26]   0.88 [0.54,1.43]   2.00 [1.17,3.42] * 1.40 [1.01,1.93] * 
  5 < Years 0.99 [0.84,1.15]   1.31 [0.87,1.98]   1.16 [0.75,1.80]   1.13 [0.89,1.45]   
Days Did Not Get Enough Sleep    
 
    
 
    
 
    
 
  
in Past Month   
 
    
 
    
 
    
 
  
 15 < Days 1 - 5 Years 1.25 [0.92,1.69]   1.54 [0.83,2.86]   1.24 [0.69,2.23]   1.61 [1.13,2.29] ** 
  5 < Years 0.99 [0.81,1.21]   1.23 [0.81,1.86]   1.28 [0.84,1.96]   1.12 [0.84,1.48]   
  1-15 Days 1 - 5 Years 1.16 [0.93,1.46]   1.22 [0.78,1.91]   1.09 [0.70,1.69]   1.25 [0.99,1.58]   
  5 < Years 0.93 [0.81,1.07]   1.23 [0.91,1.67]   1.04 [0.73,1.48]   0.98 [0.81,1.17]   
Abbreviations: AOR, Adjusted Odds Ratios; CI, Confidence Intervals;  
       Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
  Reference categories for dependent variables are as follows: Life Satisfaction (Very Satisfied/Satisfied), Activity Limitations (Yes), Perceived General Health (Excellent/Very 
Good),  
Days Perceived Physical Health Bad in Past Month (0 Days), Days Perceived Mental Health Bad in Past Month (0 Days), Received Needed Emotional Support 
(Always/Usually), 
Days Did Not Get Enough Sleep in Past Month (0 Days). 
        Results shown are adjusted for the following covariates: Presence of Cancer (no), Race/Ethnicity (White), Age (18 - 54), Marital Status (married),  
Metro Status (non-metro), Region of U.S. (Northeast), Education (< high school), Employment Status (not employed), Income (< $25,000),   
Health Insurance (no), Usual Source of Care (no), Arthritis (no), Asthma (no), CVD-MS (no), and Stroke (no).  
   Reference categories given in parenthesis. 
          CVD-MS (Cardiovascular disease-Metabolic Syndrome) includes the presence of heart disease, high cholesterol, hypertension, and or diabetes.  
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Table 5. 
Logistic Regression Comparisons of Health Related Quality of Life of Cancer Survivors by Cancer Type and Gender 
Behavioral Risk Factor Surveillance System, 2009 
  
 
Breast Cancer  Prostate Cancer  Colorectal Cancer (Female)  Breast Cancer  
  
 
Vs. Colorectal (Female) Vs. Colorectal (Male) Vs. Colorectal (Male) Vs. Prostate 
    OR 95% CI Sig. OR 95% CI Sig. OR 95% CI Sig. OR 95% CI Sig. 
Life Satisfaction   
  
  
  
  
  
  
  
  
  
Very 
Satisfied/Satisfied 0.90 [0.57,1.40]   1.68 [0.85,3.31]   2.20 [1.11,4.35] * 1.03 [0.71,1.50]   
Receive Needed Emotional Support 
  
  
  
  
  
  
  
  
  Rarely/Never 0.95 [0.60,1.49]   1.38 [0.88,2.18]   3.17 [1.76,5.71] *** 2.12 [1.58,2.84] *** 
  Sometimes 0.87 [0.53,1.43]   0.99 [0.57,1.70]   1.91 [0.99,3.69]   1.56 [1.08,2.24] * 
Activity Limitations 
  
  
  
  
  
  
  
  
  Yes 0.89 [0.69,1.15]   0.61 [0.45,0.83] ** 0.63 [0.45,0.87] ** 0.96 [0.80,1.14]   
Perceived General Health 
  
  
  
  
  
  
  
  
  Fair/Poor 0.68 [0.50,0.93] * 0.63 [0.45,0.88] ** 0.79 [0.53,1.17]   0.81 [0.65,1.01]   
  Good 1.06 [0.77,1.46]   0.79 [0.57,1.09]   0.67 [0.45,0.98] * 0.87 [0.72,1.05]   
Days Perceived Physical Health  
  
  
  
  
  
  
  
  
Bad in Past Month 
  
  
  
  
  
  
  
  
  15 < Days 0.79 [0.57,1.09]   0.89 [0.59,1.36]   1.27 [0.81,1.99]   1.05 [0.81,1.36]   
  1-15 Days 0.80 [0.59,1.07]   0.70 [0.51,0.95] * 1.18 [0.82,1.70]   1.35 [1.13,1.62] ** 
Days Perceived Mental Health  
  
  
  
  
  
  
  
  
Bad in Past Month 
  
  
  
  
  
  
  
  
  15 < Days 0.89 [0.55,1.44]   0.91 [0.49,1.70]   1.39 [0.77,2.53]   1.43 [0.96,2.11]   
  1-15 Days 0.81 [0.55,1.19]   0.94 [0.65,1.35]   1.86 [1.16,2.98] ** 1.58 [1.28,1.94] *** 
Days Didn't Get Enough Sleep  
  
  
  
  
  
  
  
  
in Past Month 
  
  
  
  
  
  
  
  
  15 < Days 0.84 [0.59,1.20]   0.88 [0.59,1.33]   1.14 [0.73,1.76]   1.33 [1.04,1.70] * 
  1-15 Days 0.89 [0.65,1.21]   0.98 [0.73,1.32]   1.53 [1.06,2.21] * 1.49 [1.26,1.77] *** 
Abbreviations: AOR, Adjusted Odds Ratios; CI, Confidence Intervals;  
     Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
 Reference categories for dependent variables are as follows: Life Satisfaction (Very Satisfied/Satisfied), Activity Limitations (Yes), Perceived General Health 
(Excellent/Very Good),  
Days Perceived Physical Health Bad in Past Month (0 Days), Days Perceived Mental Health Bad in Past Month (0 Days), Received Needed Emotional Support 
(Always/Usually), 
Days Did Not Get Enough Sleep in Past Month (0 Days). 
      Results shown are adjusted for the following covariates: Presence of Cancer (no), Race/Ethnicity (White), Age (18 - 54), Marital Status (married),  
Metro Status (non-metro), Region of U.S. (Northeast), Education (< high school), Employment Status (not employed), Income (< $25,000),   
Health Insurance (no), Usual Source of Care (no), Arthritis (no), Asthma (no), CVD-MS (no), and Stroke (no).  
 Reference categories given in parenthesis. 
        CVD-MS (Cardiovascular disease-Metabolic Syndrome) includes the presence of heart disease, high cholesterol, hypertension, and or diabetes.  
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Abstract 
Objectives 
 The objectives of this study were to compare the prevalence of specific health conditions 
and health behaviors between breast, prostate, female, and male colorectal cancer survivors to 
propensity score matched controls, and to compare health behaviors by type of cancer and 
gender.  
Methods 
 A cross-sectional study was conducted using a sample of breast, prostate, and colorectal 
cancer survivors 18 years of age and older and > 1 year past diagnosis were selected from the 
2009 BRFSS.  A greedy algorithm and matching without replacement used propensity scores to 
match 3 controls to every 1 case on age, gender, race/ethnicity, income, insurance status, and 
region of the U.S.  Health conditions compared were arthritis, asthma, heart disease, diabetes, 
hypertension, high cholesterol, stroke, activity limitations, and perceived general health.  Health 
behaviors compared were flu immunization, physical check-up, cholesterol check, BMI, physical 
activity, fruit and vegetable consumption, smoking, and alcohol use.  Chi-square tests were used 
to test for covariate balance and compared prevalence of health conditions and behaviors.  
Binomial and multinomial logistic regression models were used to estimate the probabilities of 
behaviors for cancer cases compared to controls.   
Results 
 Among a sample of 6,393 breast, 3,636 prostate, 1,111 female colorectal, and 824 male 
colorectal cancer survivors, breast and prostate cancer survivors reported a greater prevalence of 
chronic health conditions than matched controls and all survivors reported a greater prevalence 
of activity limitations and lower perception of perceived general health.  Breast cancer survivors 
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were more likely to engage in healthier behaviors 1 – 5 years after diagnosis, but were more 
likely to be obese at > 5 years after diagnosis than controls.  Male colorectal cancer survivors 
were less likely to engage in clinical preventive care at > 5 years after diagnosis than controls.  
Female colorectal and breast cancer survivors were less likely be overweight and/or obese, 
former and/or current smokers, drink any alcohol, and more likely to consume > 5 servings of 
fruits and vegetables per day, but more likely to engage in none or insufficient levels of physical 
activity compared to male colorectal and prostate cancer survivors, respectively.  
Conclusions 
 Overall, the current study findings suggest that breast and prostate cancer survivors have 
more chronic health conditions compared to matched controls than do female and male 
colorectal cancer survivors.  Breast cancer survivors are more likely to engage in healthy 
behaviors than their matched controls.  Female cancer survivors engage in healthier lifestyle 
behaviors, with the exception of physical activity, compared to male cancer survivors.  
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Introduction 
 Among the 12 million cancer survivors alive in the U.S. today, more than 2/3s are living 
five or more years post cancer diagnosis. 
1, 2
  Despite these increased survival rates, many cancer 
survivors continue to live with a diminished health-related quality of life due to the late and long 
lasting effects of the cancer and its treatment. 
3, 4
  In addition to this post treatment sequelae, a 
large proportion of cancer survivors are also experiencing the added burden of illness and 
increasing non-cancer related mortality associated with the high prevalence of obesity related 
chronic and comorbid conditions. 
5, 6
  Not only is obesity a known risk factor for many types of 
cancer, as well as cancer recurrence, but it is also the main risk factor for developing chronic 
conditions such as heart disease, metabolic syndrome, diabetes, hypertension, and high 
cholesterol. 
7, 8
  In fact, several studies have demonstrated that compared to individuals without a 
history of cancer, cancer survivors as a whole do indeed exhibit a greater number of these 
obesity related chronic and co-morbid conditions, as well as greater utilization of health care 
services and consequently, greater health care expenditures. 
9, 10, 11
  Given these findings, it is 
alarming that 70% of breast, prostate, and colorectal cancer survivors, who together comprise 
over 50% of survivors, have been found to be overweight or obese. 
2, 12, 13
  What is more, 
survivors of breast and prostate cancer treated with hormone specific therapies, specifically 
adjuvant estrogen or androgen deprivation, have been shown to be at an increased risk of 
cardiovascular disease, metabolic syndrome, diabetes, increased body fat composition, decreased 
lean muscle mass, and weight gain. 
14, 15
    
 Thus, recent research efforts have been directed towards characterizing and comparing 
the lifestyle and clinical preventive health behaviors of cancer survivors to those without a 
history of cancer, and evaluating the effectiveness of behavioral change upon the health 
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outcomes and quality of life among cancer survivors. 
9, 12, 16, 17, 18, 19, 20
  Yet, despite experiencing 
a health scare that many may consider a cue to action, the majority of cancer survivors do not 
engage in 30 minutes of moderate-to-vigorous physical activity at least 5 days a week, consume 
5 or more servings of fruits and vegetables a day, refrain from the use of tobacco, consume no 
more than 2 alcoholic drinks per day for men, and 1 drink per day for women, as recommended 
by the American Cancer Society 
17, 21
, even though these behaviors can increase cancer survival, 
functional status, and overall health, while decreasing the risk of cancer recurrence, and all-cause 
morbidity and mortality 
17, 18, 19, 22
.    
  While the general trend in study findings suggest that the majority of cancer survivors do 
not engage in superior levels of these lifestyle behaviors, compared to those without a history of 
cancer 
9, 16
, mixed study findings have left it unclear how each cancer type differs from those 
without a history of cancer, or how those with a history of cancer differ from one another with 
respect to cancer type and gender.    
Previous Research 
Comparing Individuals With & Without a History of Cancer 
 In regards to physical activity, Bellizzi et. al. reported that, as a whole, cancer survivors 
were 9% more likely to engage in recommended levels than those without a history of cancer 
23
. 
Kwon et. al. reported that, within certain age groups, prostate cancer survivors engaged in an 
average of 20 minutes more moderate physical activity per week than those without a history of 
cancer 
24
. Yet, several other studies did not find a difference in physical activity of cancer 
survivors and individuals without a history of cancer 
9, 16
.   
 Although receipt of clinical preventive care has not been as well studied as health 
behaviors, Bellizzi et. al. found that cancer survivors were more likely to receive recommended 
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routine breast and prostate cancer screenings 
23
.  A study of general clinical preventive care 
among a British cohort of breast, prostate, and colorectal cancer survivors conducted by Khan et. 
al. found that cancer survivors were no different from those without a history of cancer in receipt 
of general clinical preventive care services, such as flu immunization and blood cholesterol 
checks, but survivors of breast and prostate cancer were less likely to receive blood pressure 
screenings 
25
.   
Comparisons by Cancer Type & Gender 
 Among cancer types, study findings by Bellizzi et. al. suggest a higher proportion of 
prostate cancer survivors are more likely to engage in risky alcohol consumption compared to 
breast and colorectal cancer survivors 
23
, whereas, findings by Coups & Ostroff suggest a higher 
proportion of colorectal cancer survivors consume risky levels of alcohol when compared to 
breast and prostate cancer survivors 
16
.  A similar inconsistency exists for findings pertaining to 
nutrition.  Coups & Ostroff reported that prostate survivors are significantly more likely to 
consume > 5 servings of fruits and vegetables a day 
16
, however Mosher et. al. reported that 
breast cancer and female colorectal cancer survivors were significantly more likely to be 
consuming > 5 servings of fruits and vegetables a day, suggesting females cancer survivors may 
have a superior diet 
26
.  Clinical preventive behaviors between cancer types and genders have not 
been studied among cancer survivors.   
Statement of the Problem   
 Inconsistencies among the formerly mentioned studies may be attributable to variations 
in study design, including studies that compared non cancer controls matching only on age and 
gender 
9, 25
, or nothing at all 
16, 23, 24
, limited by small sample size 
9, 16
 or long-term (> 5 years) 
survivors only 
26
.  To control for confounding bias, a few studies stratified analysis by age and or 
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gender 
16, 24
 or used covariate adjustment 
9, 16, 23, 24
.  However, these methods may not be 
sufficient to control for confounding effects inherent to observational studies.  Reeve et. al. 
describe how propensity score matching is a superior and effective method of reducing bias in 
studies utilizing control groups to compare outcomes between cancer survivors and those without 
a history of cancer 
27
.    
 Bearing these thoughts in mind, the aims of this study are to 1) compare the health 
conditions, specifically, the presence of arthritis, asthma, heart disease, diabetes, hypertension, 
high cholesterol, and stroke, as well as, activity limitations and perceived general health between 
breast, prostate, female colorectal, and male colorectal cancer survivors to their unique non-
cancer control groups matched for age, gender, race/ethnicity, income, insurance status, and 
region of the U.S using a propensity score; 2) compare the health behaviors, including physical 
activity, fruit and vegetable consumption, smoking, and alcohol consumption, as well as, 
measures of general preventive care, including receipt of flu immunization, physical check-up, 
and blood cholesterol check between survivors of breast, prostate, female colorectal, and male 
colorectal cancer and their propensity score matched controls; 3) estimate the probabilities of 
these health behaviors using logistic regression to compare each cancer type to their propensity 
score matched controls, stratified by time since diagnosis (1 – 5 years and > 5 years) to examine 
how these behaviors may change in comparison to matched controls over the course of the 
cancer survivorship continuum; and 4) compare the estimated probabilities of these behaviors 
between cancer type (breast cancer vs. female colorectal and prostate vs. male colorectal) and 
gender (male vs. female colorectal and prostate vs. breast) using logistic regression.  These 
comparisons will not only compare cancer type, but will compare how unique experiences of 
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having had a gender or hormone-specific cancer (prostate and breast) vs. a gender-neutral cancer 
(colorectal) are associated with differential outcomes.  
 Guided by Ronald M. Andersen’s Behavioral Model of Health Services Use framework, 
the current study will examine the association between environmental, predisposing, enabling, 
need factors, and health behaviors among survivors of breast, prostate, colorectal cancers, and 
propensity score matched controls.  Andersen’s Behavioral Model is commonly used to guide 
studies utilizing national health survey data 
28
.  This study will use national population based 
survey data from the 2009 Behavioral Risk Factor Surveillance System (BRFSS) survey 
29
.  The 
environmental factors assessed are region of United States and metro status.  Predisposing 
characteristics include age, gender, race, education, and time since diagnosis.  Enabling factors 
are employment status, insurance status, income, usual source of care, and marital status.  
Measures of need are presence of cancer, type of cancer, presence of heart disease, diabetes, 
hypertension, high cholesterol, stroke, asthma, arthritis, activity limitations, and perceived 
general health status.  Measures of health behaviors include lifestyle behaviors and general 
clinical preventive care utilization.  Lifestyle behaviors include physical activity, nutritional 
intake, BMI, tobacco, and alcohol use.  General clinical preventive care includes last routine 
physical check-up, last cholesterol check, and last flu immunization.   
Methods 
Data Source 
 Study data was from the 2009 Centers for Disease Control’s national Behavioral Risk 
Factor Surveillance System (BRFSS) survey 
29
.  The BRFSS is an annual, state-based telephone 
survey administered to non-institutionalized citizens of all 50 states, the District of Columbia, 
Puerto Rico, the U.S. Virgin Islands, and Guam aged 18 years and older.  The survey collects 
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information pertaining to prevalence of diseases, risky health behaviors, preventive health care 
utilization, perceived health status, access to health care services, sociodemographic, and 
environmental characteristics.  The core component is a standard set of questions administered to 
all states and territories.  Optional modules, however, collect information of specific health 
topics and are up to the discretion of each state as to whether they will be administered.  
Moreover, additional questions that are not evaluated by the CDC may be added to the 
questionnaire by individual states.  The 2009 BRFSS response rate was 52.5%, resulting in a 
total sample size of 432,607 
30, 31
.  Post-stratification weights are used to insure representative 
national population based estimates 
32
.   All data used in this study was taken from the core 
component file, and excluded responses from Puerto Rico, the U.S. Virgin Islands, and Guam. 
Study Sample 
 The cases of breast, prostate, and colorectal cancer survivors was identified through a 
series of questions in the 2009 BRFSS.  The Cancer Survivors section of the core module begins 
by asking, “Have you ever been told by a doctor, nurse, or other health professional that you had 
cancer?” Of those who answered “yes” to this question, they were then asked, “How many 
different types of cancer have you had?”  For purposes of this study, we only included survivors 
of one primary cancer.  Cancers of the breast, prostate, colon, and rectum were identified with 
the question, “What type of cancer was it?”  Colon and rectum were combined to form colorectal 
cancer.  Male survivors of breast cancer were excluded from the sample.  Only survivors age > 
18 years were included in the sample in order to comprise an adult sample.  The question, “At 
what age were you told that you had cancer?”, allowed for the calculation of time since diagnosis 
by subtracting the age at diagnosis from the currently reported age.  To avoid the competing 
interest of possible ongoing treatment, only breast, prostate, and colorectal survivors who were  
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> 1year post diagnosis were included in the study sample.   However, questions regarding the 
type of treatment received and stage at diagnosis were not asked, and therefore these covariates 
could not be controlled for in this study.  Finally, participants with missing information for any 
dependent variables were excluded from the sample.  The final case sample consisted of 6,393 
breast, 3,636 prostate, 1,111 female, and 824 male colorectal cancer survivors. 
Measures 
Dependent Variables  
 Measures of health behaviors were classified into two categories: lifestyle behaviors and 
receipt of clinical preventive care.  Measures of lifestyle behaviors were body mass index (BMI) 
(underweight/normal, overweight, and obese); calculated variable for recommended level of 
physical activity (recommended, insufficient, and none); calculated variable for fruit and 
vegetable consumption (> 5 servings per day or < 5 servings per day); calculated variable for 
smoking status (current smoker, former smoker, and never smoked); level of alcohol 
consumption (heavy drinker, light/moderate drinker, no drinks in the past 30 days).  Level of 
alcohol consumption was calculated using calculated variables for male and female heavy 
drinkers and the number of days an individual consumed alcohol in the past 30 days.  Measures 
of clinical preventive care include time since last physical check-up (< 2 years ago, 2 – 5 years 
ago, > 5 years ago, and never), time since last cholesterol check (< 2 years ago, 2 – 5 years ago, 
> 5 years ago, and never), and received a flu immunization within the past year (yes or no).  Flu 
immunization was determined by responses to questions assessing receipt of flu shot or flu spray 
within the past year. 
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Independent Variables  
 Environmental factors were metro status (metro or non-metro) where metro = in center 
city of an MSA, outside center city of an MSA, but inside the county containing the center city, 
and inside a suburban county of the MSA and non-metro = in an MSA that has no center city and 
not in an MSA; and region of the U.S. (Northeast, Midwest, West, and South) grouped by state 
according to defined U.S census regions 
33
.  Enabling factors included marital status (married, 
widowed, separated/divorced, and never married); employment status (employed or 
unemployed) where employed = employed for wages and self-employed and unemployed = out 
of work for more than 1 year, out of work for less than 1 year, homemaker, student, retired and 
unable to work; annual household income (< $25,000, $25,000 - $35,000, $35,000 - $50,000, 
$50,000 - $75,000, >$75,000, and missing/don’t know), insurance status (insured or uninsured), 
and have a usual source of care (yes or no).   
 Predisposing factors were age (18 - 49, 50 – 54, 55 – 59, 60 – 64, 65 – 69, 70 – 74, and > 
75 years), gender (male or female), race/ethnicity (White, African American, Latino, and Other), 
education (< high school, high school graduate, some college or technical school, and college or 
technical school graduate) and time since diagnosis calculated by subtracting the cancer 
survivor’s age at diagnosis from their current age.   
 Measures of need were considered to be the presence of specific health conditions 
according to an affirmative response to ever being told so by a health professional.  Health 
conditions are as follows: heart disease (answered yes to ever been told to have myocardial 
infarction, angina or coronary heart disease), hypertension (yes to every been told to have high 
blood pressure), high cholesterol (adults who had their blood cholesterol checked and told it was 
high), diabetes (yes to ever been told to have it, have it only during pregnancy, or borderline 
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diabetes),  stroke (yes to ever been told to have had a stroke), asthma (yes to ever been told to 
have asthma), and arthritis (yes to ever been told to arthritis).  Measures of need also included 
activity limitations (answering yes to being limited in any way in any activities because of 
physical, mental, or emotional problems) and perceived general health status (excellent, very 
good, good, fair, or poor).   
Analysis 
Propensity Score Matched Controls 
 Like the cancer cases, potential controls were selected if they were of age > 18 years and 
did not have missing responses for the dependent variables.  Logistic regression was used to 
derive a propensity score for each case and potential control based upon the probability of the 
individual having cancer and belonging to various categories of age, gender, race/ethnicity, 
income, insurance status, and region of the U.S.  Matching without replacement was performed 
using a greedy matching algorithm to assign three controls to every case.  A 3:1 control sample 
was used to control for the effects of any remaining bias.  After matching, Chi-square tests were 
performed to determine if balance was achieved on the covariates between the cases and 
controls.   
Statistical Methods 
 Descriptive statistics and Chi-square tests were performed to compare socio-demographic 
factors, health conditions, and health behaviors between cases and controls.  Differences were 
determined to be significant for p values < .05.  The probabilities of engaging in specified levels 
of health behaviors were compared between cases and controls using binary and multinomial 
logistic regression adjusting for selected covariates.  Regression models were stratified by time 
since diagnosis (1 – 5 years and > 5 years), preserving the propensity score matched control 
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pairings for each group of survivors.  The same health behavior comparisons were modeled 
between the types of cancers and genders, omitting the time since diagnosis stratifications.  
Specific covariates adjusted for in regression models were the presence of cancer (case vs. 
control comparisons only), race/ethnicity, age, marital status, metro status, region of the U.S., 
education, employment, income, health insurance, usual source of care, CVD-MS 
(Cardiovascular Disease - Metabolic Syndrome, includes the presence of heart disease, high 
cholesterol, hypertension, and or diabetes), stroke, asthma, arthritis, activity limitations, and 
general perceived health status.  Health behaviors modeled using binary logistic regression were 
last flu immunization (< 1 year),  last routine physical check-up (< 2 years) (categories were 
collapsed to < 2 years or > 2 years due to small cell sizes for other times), last cholesterol check 
(< 2 years) (categories were collapsed to < 2 years or > 2 years due to small cell sizes for other 
times), alcohol consumption (light/moderate drinker) (categories were collapsed to drink or don’t 
drink due to small number of responses to heavy drinker) and fruit and vegetable consumption (> 
5 servings/day).  Health behaviors modeled using multinomial logistic regressions were modeled 
for smoking status (never smoked), BMI (underweight/normal), and physical activity 
(recommended level).  Reference categories are shown in parenthesis.  Parameter estimates 
calculated in the regression models were converted to odds ratios and corresponding 95% 
confidence intervals.   
 Data was weighted so that all estimates provided are nationally representative.  Post-
stratification weighs were applied to the data before the propensity score matching process.  All 
analysis were conducted using SAS version 9.2 software (SAS Institute Inc., Cary, NC), to 
account for the complex sample design. 
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Results 
Description: Table 1 
 While the majority of breast (28.7%), female colorectal (39.5%), male colorectal (29.9%) 
and prostate (45.3%) cancer survivors were 75 years of age and older.  The four cancer groups 
were predominantly white (78.6% - 83.3%), married (56.4% - 77.1%), unemployed (63.8% - 
76.6%), insured (95.7% - 97.9%), reporting a usual source of care (94.6% - 96.4%), residing in 
the South region of the U.S. (33.8% - 40.3%), and living in a metropolitan area (77.9% - 82.1%).  
The majority of breast, male colorectal, and prostate cancer survivors were a college or technical 
school graduate, whereas the majority of female colorectal cancer survivors were only a high 
school graduate.  Most prostate cancer survivors had an annual income of $75,000 or more, 
whereas most breast, female and male colorectal cancer survivors had an annual income less than 
$25,000.       
 Balance was achieved between cancer survivors and their matched controls on covariate 
measures modeled in the propensity score matching process.  Breast cancer survivors were more 
likely to report being a college or technical school graduate compared to their matched controls 
(36.5% vs. 32.1%) (p < .000) and prostate cancer survivors were more likely to report being 
unemployed compared to their matched controls (76.2% vs. 73.1%) (p = .049).  All cancer 
survivor groups except for female colorectal were more likely to report having a usual source of 
care (p < .000) compared to their matched controls.   
Aim 1: Table 2 
 All four cancer groups were significantly more likely to report activity limitations 
compared to their matched controls, ranging in 29.3% (p = .005) among prostate cancer 
survivors to 39.4% (p < .000) among male colorectal cancer survivors.  Similarly, all four cancer 
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groups were more likely to report perceiving their general health status as good or fair/poor (p < 
.000) compared to their matched controls, whereas, the controls were more likely to report 
perceiving their general health status as excellent/very good.  Breast cancer survivors reported an 
increased prevalence of arthritis (52.9% vs. 48.4%) (p = .001), diabetes (17.8% vs. 15.9%) (p = 
.050), and high cholesterol (48.7% vs. 46.1%) (p = .001) compared to their matched controls.  
Similarly, prostate cancer survivors reported an increased prevalence of arthritis (47.8% vs. 
41.5%) (p < .000), hypertension (58.2% vs. 53.7%) (p = .007), and high cholesterol (53.8% vs. 
48.1%) (p < .000) compared to their matched controls.  Male colorectal cancer survivors reported 
an increased prevalence of asthma (13.3% vs. 8.0%) (p = .003) compared to their matched 
controls.  
Aim 2: Table 3  
  Breast cancer survivors were more likely to report having had a flu immunization within 
the past year (63.7% vs. 57.5%) (p < .000), physical check-up within the past 2 years (93.7% vs. 
91.4%) (p < .000), and cholesterol check within the past 2 years (90.9% vs. 87.5%) (p < .000) 
compared to their matched controls.  Likewise, prostate cancer survivors were more likely to 
report having had a flu immunization within the past year (70.9% vs. 65.7%) (p = .002), physical 
check-up within the past 2 years (95.6% vs. 92.9%) (p < .000), and cholesterol check within the 
past 2 years (94.5% vs. 91.0%) (p < .000) than their matched controls.  Neither female nor male 
colorectal cancer survivors were more likely to receive routine general clinical preventive care 
than their matched controls.  Breast cancer survivors reported a greater prevalence of being 
overweight (34.4% vs. 31.9%) (p = .047) than their matched controls.  Female colorectal (30.9% 
vs. 38.4%) (p = .001), male colorectal (39.6% vs. 46.8%) (p = .035), and prostate cancer 
survivors (46.5% vs. 47.1%) (p = .022) engaged less often in the recommended levels of physical 
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activity and more often in the insufficient levels of physical activity (48.2% vs. 38.4%), (44.6% 
vs. 38.1%), and (39.2% vs. 35.9%), respectively.  Only breast cancer survivors consumed > 5 
servings of fruits and vegetables a day (34.6% vs. 31.7%) (p = .025) more often than their 
matched controls.  Female colorectal cancer survivors reported an increased prevalence of 
current smoking (11.8% vs. 10.9%) and former smoking (36.2% vs. 29.2%) (p = .048) status 
than their matched controls.  Prostate cancer survivors reported a decreased prevalence of current 
smoking status (7.9% vs. 10.4%) and higher prevalence of having never smoked (41.2% vs. 
38.3%) (p = .019).  
Aim 3: Table 4 
 Adjusted models showed that breast cancer survivors 1 – 5 years after diagnosis were 
44% more likely (OR = 1.44, 95% CI: 1.16 – 1.80) to reporting having received a flu 
immunization within the past year compared to their matched controls, but at > 5 years after 
diagnosis, they were only 16% more likely (OR = 1.16, 95% CI: 1.01 – 1.33) to report having 
received a flu immunization within the past year.  Breast cancer survivors 1 – 5 years after 
diagnosis were less likely to be overweight (OR = 0.78, 95% CI: 0.67 – 0.92) than 
normal/underweight compared to their matched controls, but at > 5 years after diagnosis, they 
were about 30% more likely to be obese (OR = 1.29, 95% CI: 1.02 – 1.64) than 
normal/underweight than their matched controls.  Compared to their matched controls, breast 
cancer survivors 1 – 5 years after diagnosis were about 40% more likely to consume > 5 servings 
of fruits and vegetables a day (OR = 1.39, 95% CI: 1.13 – 1.72), but were no more likely to meet 
this recommendation than their matched controls when > 5 years after diagnosis.  Breast cancer 
survivors 1 – 5 years after diagnosis were almost 40% less likely to be current smokers than 
never have smoked (OR = 0.63, 95% CI: 0.45 – 0.87) than their matched controls.  
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  Female colorectal cancer survivors 1 – 5 years after diagnosis were over 40% less likely 
to be obese than normal/underweight (OR = 0.59, 95% CI: 0.35 – 0.99) than their matched 
controls.  At 1 – 5 years after diagnosis, female colorectal cancer survivors are about 60% less 
likely to report no physical activity (OR = 0.42, 95% CI: 0.23 – 0.77) than the recommended 
level, and those > 5 years after diagnosis were about 40% more likely to report insufficient levels 
of physical activity than the recommended level (OR = 1.41, 95% CI = 1.03 – 1.94) than their 
matched controls.   
 Male colorectal cancer survivors > 5 years after diagnosis were almost 60% (OR = 0.42, 
95% CI: 0.24 – 0.74) and 50% less likely (OR = 0.51, 95% CI: 0.28 – 0.95) to have received a 
physical check-up and a cholesterol check within the past 2 years compared to their matched 
controls.   
 Prostate cancer survivors 1 – 5 years after diagnosis were 35% less likely (OR = 0.65, 
95% CI: 0.48 – 0.89) to report no physical activity than the recommended level compared to 
their matched controls.      
Aim 4: Table 5 
 Compared to female colorectal cancer survivors, survivors of breast cancer were 25% 
less likely (OR = 0.75, 95% CI: 0.57 – 0.98) to engage in insufficient levels of physical activity 
than the recommended level. Prostate cancer survivors did not significantly differ from male 
colorectal cancer survivors. 
  Compared to male colorectal cancer survivors, female survivors of colorectal cancer 
were about 50% less likely (OR = 0.43, 95% CI: 0.30 – 0.61) to be overweight than 
normal/underweight and 75% more likely (OR = 1.76, 95% CI: 1.23 – 2.52) to consume > 5 
servings of fruits and vegetables a day.  Female colorectal cancer survivors were also 50% less 
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likely to be a former smoker than having never smoked, and about 35% less likely (OR = 0.64, 
95% CI: 0.45 – 0.92) to drink any amount of alcohol in the past 30 days compared to male 
colorectal cancer survivors.   
 Compared to prostate cancer survivors, survivors of breast cancer about 40% less likely 
(OR: 0.57, 95% CI: 0.46 – 0.71) to be obese and 50% less likely (OR = 0.49, 95% CI: 0.41 – 
0.59) to be overweight.   Breast cancer survivors were also more than twice as likely (OR = 2.29, 
95% CI: 1.92 – 2.74) to consume > 5 servings of fruits and vegetables a day than prostate cancer 
survivors, but were 65% more likely (OR = 1.65, 95% CI: 1.31- 2.06) to report no physical 
activity than the recommended level and about 30% more likely (OR = 1.28, 95% CI: 1.07 – 
1.52) to report insufficient levels of physical activity than the recommended level compared to 
prostate cancer survivors. Yet, breast cancer survivors were 45% less likely (OR = 0.55, 95% CI: 
0.41 – 0.73) to be a current smoker than never smoked, 56% less likely (OR = 0.44, 95% CI: 
0.38 – 0.52) to be a former smoker than never smoked, and 46% less likely (OR = 0.54, 95% CI: 
0.46 – 0.63) to drink any alcohol in the past thirty days compared to prostate cancer survivors.   
Discussion 
 This study is the first to have compared both prevalence of chronic and comorbid 
conditions and health behaviors among the three largest groups of cancer survivors in the U.S. to 
controls using the propensity score matching method to rigorously control for the effects of 
confounding bias.  This study further extends the extant literature by comparing health behaviors 
between the breast, prostate and colorectal cancer survivors by cancer type and gender to identify 
differences associated with either having had a gender-specific or gender-neutral cancer and/or 
gender itself.       
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 All survivors were much more likely to report the presence of activity limitations and less 
likely to perceive their general health to be excellent or very good than their matched controls.  
Survivors of breast and prostate cancer exhibited a greater number of obesity related chronic and 
comorbid conditions, including high cholesterol, diabetes and/or hypertension, as well as 
arthritis, compared to their matched controls than did survivors of colorectal cancer. Moreover, 
survivors of breast cancer who were living > 5 years past diagnosis were almost 30% more likely 
to be obese compared to their matched controls.  These differences in the presence of chronic 
and comorbid health condition between breast and prostate compared to colorectal cancer 
survivors may in part be explained by the adverse health risks associated with the use of the sex-
hormone modifying therapies commonly used to treat breast and prostate cancer.  Survivors of 
breast cancer treated with adjuvant hormone therapy and prostate cancer treated with androgen 
deprivation therapy have been shown to be at an increased risk of metabolic syndrome, 
cardiovascular disease, diabetes, and weight gain 
14, 15, 34
.   
 Prevalence comparison of cancer survivors to their matched controls, demonstrated that 
survivors of breast and prostate cancer engaged in higher rates of all three general clinical 
preventive care services, while female and male colorectal cancer survivors did not differ in 
receipt of any clinical preventive care service compared to their controls.  In regards to lifestyle 
behaviors, only breast cancer survivors were more likely to meet recommended levels of fruit 
and vegetable consumption compared to matched controls.  Survivors of prostate and both male 
and female colorectal cancers reported lower levels of recommended physical activity and higher 
rates of the insufficient levels compared to their matched controls.  Prostate cancer survivors 
self-identified as current smokers less frequently and more frequently as never having smoked 
than did their controls.  Female colorectal cancer survivors more frequently reported themselves 
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to be current and former smokers than did their matched controls, but less reported having never 
smoked.   
 However, after adjusting for covariates, logistic regression models of receipt of general 
clinical preventive care stratified by time since diagnosis showed that only survivors of breast 
cancer at both times since diagnosis were more likely to have received a flu immunization within 
the past year compared to their controls.  Male colorectal cancer survivors > 5 years after 
diagnosis were less likely to have received blood cholesterol screenings and physical check-ups 
than their matched controls.  With respect to lifestyle behaviors, prostate and female colorectal 
cancer survivors were both less likely than their matched controls to report no physical activity 1 
– 5 years after diagnosis, but female colorectal cancer survivors were about 40% more likely 
report insufficient levels of activity > 5 years after diagnosis.  Breast cancer survivors 1 – 5 years 
after diagnosis remained about 40% more likely to consume > 5 servings of fruits and vegetables 
per day than their matched controls and about 40% less likely to be current smokers.   
 These findings differ slightly from previous studies that compared the individual cancer 
types to those without a history of cancer.  Khan and colleagues (2010) compared clinical 
preventive care behaviors of breast, prostate, and colorectal cancer survivors in the United 
Kingdom to controls matched on age and gender.  They found that all three cancer groups were 
superior in receipt of flu immunization compared to matched controls, but were no different 
cholesterol screening 
26
.  Eakin and colleagues (2007) compared health behaviors among a small 
sample of breast, prostate, and colorectal cancer survivors in Australia to controls matched on 
age and gender.  Regression models did not identify differences between breast and female 
colorectal survivors and controls, but prostate male colorectal cancer survivors were more likely 
to have regular skin checks and male colorectal cancer survivors were less likely than controls to 
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be sedentary.  However, prostate cancer survivors were more likely to consume moderate 
amounts of alcohol 
9
.  A recent study by Kwon and colleagues (2011) utilizing the same data set 
as this study (2009 BRFSS), compared the prevalence rates for physical activity among breast, 
prostate, and colorectal cancer survivors age 40 – 64 and 65 – 79 years to all others in these age 
groups without a history of cancer. Prevalence rates for engaging in recommended levels 
physical activity and median minutes of physical activity per week were similar between 
survivors of breast cancer and those without a history of cancer, but female survivors of 
colorectal cancer had lower rates of each compared to those without a history of cancer.  A 
similar pattern was observed among prostate and male colorectal cancer survivors.  Survivors of 
prostate were similar to those without a history of cancer with respect to prevalence of engaging 
in recommended levels of physical activity, but those 40 – 64 years of age reported participating 
in 20 minutes of moderate physical activity per week than those without a history of cancer.  
Male colorectal cancer survivors engaged in lower levels for both measures of physical activity 
compared to those without a history of cancer 
24
.          
 Thus far, cancer vs. control comparisons have demonstrated that survivors of a gender or 
hormone-specific cancer such as breast and prostate demonstrated a greater prevalence of obesity 
related chronic and comorbid conditions compared to their controls, which may explain their 
increased participation in routine general clinical preventive care services compared to their 
controls.  Yet, there were very few differences in regards to lifestyle behaviors between any of 
the survivors and their controls.   
 A different pattern emerged when health behaviors were compared between the cancer 
types and genders.  When breast cancer survivors were compared to female colorectal cancer 
survivors and prostate survivors were compared to male colorectal cancer survivors, almost no 
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differences were observed between the gender-specific and gender-neutral cancers.  However, 
when female colorectal cancer survivors were compared to male colorectal cancer survivors and 
breast cancer survivors were compared to prostate cancer survivors, numerous differences 
emerged.  Both groups of female cancer survivors were less likely to be overweight and/or 
obese, more likely to consume > 5 servings of fruits and vegetables per day, less likely to be 
former and/or current smokers, and less likely to drink any alcohol compared to their male 
counterparts.  Breast cancer survivors were however, more likely to engage in no or insufficient 
levels of physical activity compared to prostate cancer survivors.  These findings suggest that, in 
comparison to male cancer survivors, females engage in equal or superior levels of every 
behavior except physical activity, the one behavior that has been the promoted the most among 
these groups of survivors, particularly among survivors of breast cancer.  A study comparing 
lifestyle factors among older, long-term breast, prostate, and colorectal cancer survivors 
identified a similar pattern relative to diet and exercise.  Mosher and colleagues [2009] found 
that survivors of breast cancer had a better diet quality, but engaged in less physical activity than 
both prostate and male colorectal cancer survivors, and female colorectal cancer survivors had a 
better diet quality than male colorectal cancer survivors 
25
.  This phenomenon of men engaging 
in higher levels of physical activity, but maintaining a poorer diet as compared to women, and 
vice versa has not been limited to cancer survivors.  A study of gender differences in relation the 
physical activity and life satisfaction among patients with coronary heart disease also found a 
higher prevalence of physical activity among men as compared to women 
35
.  Furthermore, a 
large study of young adults across countries found that compared to men, women reported 
avoiding high fat foods and salt, but consuming more fruit and high fiber foods 
36
.   
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 This study utilized data from a relatively recent and large national survey.  Breast, 
prostate, and colorectal cancer survivors sampled represented a diverse range in age and time 
since diagnosis.  A rigorous method of matching cases to controls was used to control for the 
effects of confounding bias.  This study comprehensively compared the presence of chronic and 
comorbid health conditions and health behaviors between cancer survivors and their matched 
controls, while also comparing health behaviors between cancer types and genders.  However, 
inherent in self-reported data is responder bias, particularly for self-reported physical activity.  
While the this study did not adjust for stage of diagnosis or type of treatment, the sample of 
cancer survivors were limited to those who were > 1 year past diagnosis to avoid survivors who 
may still be undergoing treatment and therefore have competing interest with engaging in 
healthy behaviors.  Furthermore, the association between time since diagnosis and health 
behaviors was examined by stratifying comparisons by short-term (1 – 5 years) and long-term (> 
5 years) cancer survivors.  In addition to the three measures of clinical preventive care, cancer 
screenings including mammogram, pap test, prostate specific antigen test, and colonoscopy are 
also recommended routinely among the majority of the age groups sampled, but were not able to 
be examined in this study.   
Conclusions 
 In conclusion, this study demonstrated that survivors of breast and prostate cancer having 
a greater prevalence of certain chronic and comorbid health condition compared to matched 
controls than did female and male colorectal cancer survivors.  In accordance with these 
findings, survivors of breast and prostate cancer received clinical preventive care services more 
frequently compared to their matched controls than did female and male colorectal cancer 
survivors.  Comparisons of healthy lifestyle behaviors between survivors and controls resulted in 
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mixed findings according to cancer type.  Yet, none of the cancer survivors engaged in superior 
levels of physical activity compared to their controls.  Only survivors of breast cancer had higher 
rates of consuming > 5 servings of fruits and vegetables per day than their controls.  However, 
comparisons between male and female cancer survivors revealed that the women engage in 
superior or equal levels of all health behaviors, except physical activity, while the men lack in 
their intake of fruits and vegetables.  Given these findings, it is necessary for health care 
providers to be aware of the increased burden of illness among survivors of breast and prostate 
cancer in comparison to others in their cohort in order to provide proper monitoring, treatment 
and health promotion.  Moreover, provider awareness of health behavior disparities in physical 
activity and diet according to gender can help guide individualized counseling to target desired 
behaviors among cancer survivors.   
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Table 1. 
Description of Cancer Survivors and Matched Controls 
Behavioral Risk Factor Surveillance System, 2009 
  
 
BC  BC Controls Sig. CC  (Female) CC Controls Sig. CC (Male) CC Controls Sig. PC  PC Controls Sig. 
  
 
N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value 
All 6393 25.0 19179 75.0   1111 25.0 3333 75.0   824 25.0 2472 75.0   3636 25.0 10908 75.0   
Age 
    
0.426 
    
0.967 
    
0.936 
    
0.151 
  18 - 49 390 10.2 1170 12.0 
 
40 6.8 120 8.0 
 
36 8.8 108 10.9 
 
18 1.1 54 2.6 
   50 - 54 477 10.6 1432 10.0 
 
57 8.2 170 8.6 
 
37 6.5 111 6.8 
 
63 3.4 189 2.7 
   55 - 59 703 12.2 2119 11.7 
 
90 7.8 270 8.6 
 
75 10.4 225 9.3 
 
171 5.8 516 6.3 
   60 - 64 906 13.0 2716 13.7 
 
114 10.6 342 10.4 
 
115 14.9 347 14.6 
 
412 13.2 1240 13.2 
   65 - 69 989 13.4 2959 13.2 
 
129 10.4 388 9.2 
 
141 15.8 425 16.4 
 
602 13.3 1815 14.8 
   70 - 74 938 11.9 2820 12.2 
 
190 16.7 570 15.0 
 
126 13.7 377 12.7 
 
735 17.8 2175 18.3 
   > 75 1990 28.7 5963 27.2 
 
491 39.5 1473 40.1 
 
294 29.9 879 29.4 
 
1635 45.3 4919 42.0 
 Gender 
    
1.000 
    
1.000 
    
1.000 
    
1.000 
  Female 6393 100.0 19179 100.0 
 
1111 100.0 3333 100.0 
 
0 0.0 0 0.0 
 
0.0 0.0 0.0 0.0 
   Male 0 0.0 0 0.0 
 
0 0.0 0 0.0 
 
824 100.0 2472 100.0 
 
3636 100.0 10908 100.0 
 Race/Ethnicity 
    
0.280 
    
0.281 
    
0.456 
    
0.561 
  White 5559 80.6 16681 81.6 
 
971 83.3 2913 80.3 
 
704 80.7 2116 79.8 
 
3057 78.6 9203 77.7 
   AA 407 9.9 1226 7.9 
 
78 10.5 231 8.8 
 
53 10.2 154 8.2 
 
355 12.4 1039 13.3 
   Latino 163 5.2 483 5.4 
 
26 2.1 79 5.2 
 
33 6.3 97 7.9 
 
93 5.5 277 4.6 
   Other 264 4.3 789 5.1 
 
36 4.2 110 5.6 
 
34 2.8 105 4.0 
 
131 3.6 389 4.4 
 Marital Status 
    
0.107 
    
0.296 
    
0.401 
    
0.192 
  Married 3019 59.4 9174 58.9 
 
442 56.4 1321 52.0 
 
524 75.0 1614 75.3 
 
2501 77.1 7263 75.8 
   Widowed 1978 22.3 6169 22.8 
 
446 26.8 1362 30.9 
 
142 11.1 377 8.9 
 
561 10.6 1877 11.6 
   Sep/Divorced 1030 13.4 2813 12.1 
 
178 13.4 501 13.0 
 
107 9.4 334 10.8 
 
405 9.1 1228 8.3 
   Never Married 366 4.9 1023 6.2 
 
45 3.4 149 4.1 
 
51 4.4 147 5.0 
 
169 3.3 540 4.3 
 Education 
    
0.000*** 
    
0.367 
    
0.114 
    
0.606 
  < HS 445 6.4 1762 8.8 
 
142 15.2 415 13.9 
 
99 11.7 287 11.4 
 
385 9.7 1235 10.5 
   HS Grad 2008 29.6 6537 31.9 
 
414 36.4 1256 33.6 
 
264 30.5 747 28.8 
 
979 25.4 3151 26.7 
   Some Col/TS 1832 27.5 5297 27.2 
 
324 26.6 836 25.6 
 
193 25.5 557 21.0 
 
795 22.7 2382 22.5 
   Col/TS Grad 2108 36.5 5583 32.1 
 
231 21.9 826 26.9 
 
268 32.3 881 38.9 
 
1477 42.1 4140 40.3 
 Employment Status 
    
0.062 
    
0.332 
    
0.822 
    
0.049 * 
  Employed  1935 33.1 6054 35.5   216 23.9 747 26.8   248 36.2 736 36.9   795 23.8 2662 26.9   
  Unemployed 4458 66.9 13125 64.5   895 76.1 2586 73.2   576 63.8 1736 63.1   2841 76.2 8246 73.1   
Family Income 
    
0.191 
    
0.585 
    
0.433 
    
0.993 
  < $25,000 1884 24.9 5658 24.6   442 31.9 1331 34.6   245 26.2 738 28.3   798 19.5 2383 19.7   
  $25,000 - $35,000 849 10.9 2545 12.1   150 12.2 454 13.1   114 13.4 342 11.7   501 12.1 1492 11.6   
  $35,000 - $50,000 932 14.6 2788 14.6   136 12.5 402 12.2   124 14.7 370 12.8   641 17.5 1934 17.2   
  $50,000 - $75,000 758 12.0 2267 13.1   96 12.6 288 10.6   112 16.8 336 14.2   575 15.7 1694 15.5   
  > $75,000 1084 22.8 3253 22.8   117 13.5 348 15.3   158 22.1 476 25.7   776 25.0 2312 25.8   
  Missing/DK 886 14.8 2668 12.7   170 17.3 510 14.2   71 6.9 210 7.3   345 10.2 1093 10.2   
Abbreviations: BC, Breast Cancer; CC, Colorectal Cancer; PC, Prostate Cancer; AA, African American; Sep, Separated; HS, High School; Grad, Graduate; Col, College;  TS, Technical School; DK, Don't Know;     
Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
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Table 2. 
Health Conditions of Cancer Survivors and Matched Controls 
Behavioral Risk Factor Surveillance System, 2009 
  
 
BC  BC Controls Sig. CC  (Female) CC Controls Sig. CC (Male) CC Controls Sig. PC  PC Controls Sig. 
  
 
N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value N Wt. % N Wt. % p value 
All 6393 25.0 19179 75.0   1111 25.0 3333 75.0   824 25.0 2472 75.0   3636 25.0 10908 75.0   
Arthritis 
    
0.001** 
    
0.083 
    
0.068 
    
0.000*** 
  Yes 3591 52.9 10003 48.4   665 60.6 1873 55.0   353 46.3 1061 41.0   1815 47.8 4714 41.5   
  No 2788 47.1 9121 51.6   442 39.4 1447 45.0   469 53.7 1404 59.0   1814 52.2 6133 58.5   
Asthma 
    
0.568 
    
0.947 
    
0.003** 
    
0.637 
  Yes 832 13.4 2477 13.9   148 12.5 384 12.4   94 13.3 214 8.0   366 9.5 916 9.0   
  No 5542 86.6 16656 86.1   958 87.5 2941 87.6   728 86.7 2253 92.0   3263 90.5 9954 91.0   
Heart Disease 
    
0.260 
    
0.580 
    
0.538 
    
0.093 
  Yes 670 8.9 2029 9.7   158 12.7 425 11.7   177 18.9 578 20.2   780 20.1 2524 22.3   
  No  5657 91.1 16954 90.3   944 87.3 2861 88.3   640 81.1 1864 79.8   2807 79.9 8260 77.7   
Diabetes 
    
0.050* 
    
0.445 
    
0.184 
    
0.722 
  Yes 1144 17.8 3121 15.9   246 18.8 639 20.5   216 25.1 579 21.8   814 23.6 2517 23.1   
  No 5245 82.2 16049 84.1   865 81.2 2693 79.5   606 74.9 1889 78.2   2819 76.4 8380 76.9   
Hypertension 
    
0.779 
    
0.301 
    
0.096 
    
0.007** 
  Yes 3268 46.4 9730 46.8   636 56.7 1877 53.4   455 53.1 1313 48.3   2194 58.2 6065 53.7   
  No 3118 53.6 9412 53.2   473 43.3 1444 46.6   368 46.9 1150 51.7   1439 41.8 4819 46.3   
High Cholesterol 
    
0.001** 
    
0.399 
    
0.913 
    
0.000*** 
  Yes 3246 48.7 9318 46.1   554 47.0 1692 48.3   390 49.3 1220 48.8   1982 53.8 5321 48.1   
  No 2957 48.0 8957 48.2   519 49.5 1492 46.6   397 46.4 1142 46.3   1562 43.7 5118 47.2   
  No Test 190 3.4 904 5.7   38 3.5 149 5.1   37 4.3 110 4.8   92 2.5 469 4.7   
Stroke 
    
0.497 
    
0.512 
    
0.694 
    
0.870 
  Yes 327 4.7 1051 5.0   90 8.0 206 6.7   56 6.4 190 6.9   266 6.9 814 6.7   
  No 6047 95.3 18077 95.0   1018 92.0 3113 93.3   765 93.6 2277 93.1   3358 93.1 10064 93.3   
Activity Limitations 
    
0.000*** 
    
0.004** 
    
0.000*** 
    
0.005** 
  Yes 2043 30.6 5401 25.6   389 37.0 1011 28.4   296 39.4 720 23.9   1117 29.3 2972 25.2   
  No 4328 69.4 13702 74.4   716 63.0 2305 71.6   524 60.6 1742 76.1   2505 70.7 7896 74.8   
Perc. General Health 
    
0.000*** 
    
0.000*** 
    
0.000*** 
    
0.000*** 
  Excel/Very Good 2426 41.7 8976 52.8   333 32.3 1364 44.9   243 31.8 1038 48.5   1260 38.1 4534 46.1   
  Good 2162 36.5 5531 29.1   351 32.9 990 31.7   266 39.5 700 30.4   1238 38.9 3419 33.8   
  Fair/Poor 1424 21.8 3465 18.1   329 34.8 736 23.3   240 28.7 556 21.2   882 23.1 2147 20.2   
Abbreviations: BC, Breast Cancer; CC, Colorectal Cancer; PC, Prostate Cancer; AA, African American; Perc, Perceived; Excel, Excellent; 
    Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
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Table 3. 
Comparison of Health Behaviors of Cancer Survivors and Matched Controls 
Behavioral Risk Factor Surveillance System, 2009 
  
 
BC  BC Controls Sig. CC (Female) CC Controls Sig. CC (Male) CC Controls Sig. PC  PC Controls Sig. 
  
 
N 
Wt. 
% N 
Wt. 
% p value N 
Wt. 
% N 
Wt. 
% p value N 
Wt. 
% N 
Wt. 
% 
p 
value N 
Wt. 
% N 
Wt. 
% p value 
All   6393 25.0 19179 75.0   1111 25.0 3333 75.0   824 25.0 2472 75.0   3636 25.0 10908 75.0   
Flu Immunization < 1 Year   
   
0.000*** 
    
0.642 
    
0.490 
    
0.002** 
  Yes 4282 63.7 11752 57.5   767 62.7 2149 61.3   523 60.1 1548 58.1   2649 70.9 7367 65.7   
  No 2111 36.3 7427 42.5   344 37.3 1184 38.7   301 39.9 924 41.9   987 29.1 3541 34.3   
Physical Check-up   
   
0.000*** 
    
0.629 
    
0.063 
    
0.000*** 
  < 2 years ago 5955 93.7 17365 91.4   1033 94.0 3057 91.9   750 91.2 2231 91.3   3435 95.6 9995 92.9   
  2 - 5 years ago 217 3.6 807 3.9   40 2.8 110 3.5   41 4.2 107 4.2   101 2.2 409 3.1   
  > 5 years ago 179 2.3 880 4.1   28 2.7 139 3.8   30 3.4 125 4.3   94 2.2 459 3.4   
  Never 42 0.4 127 0.6   10 0.5 27 0.8   3 1.2 9 0.2   6 0.0 45 0.6   
Cholesterol Check   
   
0.000*** 
    
0.568 
    
0.183 
    
0.000*** 
  < 2 years ago 5758 90.9 16801 87.5   998 91.6 2938 89.6   729 90.3 2200 87.9   3389 94.5 9822 91.0   
  2 - 5 years ago 269 4.2 848 4.8   40 3.9 130 3.8   37 2.5 89 5.2   95 2.2 334 2.9   
  > 5 years ago 113 1.5 454 2.0   17 1.0 78 1.5   16 3.0 53 2.0   33 0.8 203 1.5   
  Never 190 3.4 904 5.8   38 3.5 149 5.1   37 4.3 110 4.9   92 2.5 469 4.7   
BMI   
   
0.047* 
    
0.668 
    
0.150 
    
0.751 
  Underweight/Normal 2529 41.1 7771 41.0   437 38.0 1342 39.9   219 25.4 679 28.2   1010 28.3 3182 28.8   
  Overweight 2254 34.4 6420 31.9   369 30.9 1114 31.5   351 44.3 1125 46.5   1748 47.1 5019 45.9   
  Obese 1610 24.4 4988 27.0   305 31.1 877 28.6   254 30.3 668 25.3   878 24.5 2707 25.3   
Physical Activity   
   
0.626 
    
0.001** 
    
0.035* 
    
0.022* 
  Recommended Level 2646 41.4 7994 42.6   392 30.9 1266 38.4   318 39.6 1146 46.8   1694 46.5 5018 47.1   
  Insufficient  Level 2559 41.4 7643 40.2   442 48.2 1298 38.4   343 44.6 883 38.1   1326 39.2 3903 35.9   
  None 1188 17.2 3542 17.2   277 20.9 769 23.2   163 15.8 443 15.0   616 14.3 1987 17.0   
Fruits and Vegetables   
   
0.025* 
    
0.088 
    
0.581 
    
0.501 
  5 < Servings/Day  2075 34.6 5951 31.7   319 28.7 1064 33.5   153 19.9 500 21.3   806 21.5 2307 22.5   
  5 > Servings/Day  4318 65.4 13228 68.3   792 71.3 2269 66.5   671 80.1 1972 78.7   2830 78.5 8601 77.5   
Smoking Status   
   
0.062 
    
0.048* 
    
0.213 
    
0.019* 
  Current Smoker 637 10.3 2258 12.3   130 11.8 340 10.9   89 10.9 318 14.2   297 7.9 1082 10.4   
  Former Smoker 2168 31.2 5997 29.6   395 36.2 1044 29.6   457 51.0 1240 47.6   1932 50.9 5817 51.4   
  Never Smoked 3588 58.4 10924 58.1   586 52.0 1949 59.5   278 38.1 914 38.2   1407 41.2 4009 38.3   
Alcohol   
   
0.497 
    
0.326 
    
0.135 
    
0.628 
  Heavy Drinker 280 3.9 758 4.4   30 2.9 109 4.7   40 4.7 86 3.5   130 3.9 389 4.0   
  Light/Moderate Drinker 2301 38.4 6764 37.3   317 33.0 984 30.8   372 45.1 1160 50.5   1716 50.7 5116 49.0   
  None in last 30 days 3812 57.6 11657 58.4   764 64.0 2240 64.5   412 50.2 1226 46.0   1790 45.5 5403 47.0   
Abbreviations: BC, Breast Cancer; CC, Colorectal Cancer; PC, Prostate Cancer;  
             Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
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Table 4. 
Logistic Regression of the Health Behaviors of Cancer Survivors to Matched Controls 
Behavioral Risk Factor Surveillance System, 2009 
      Breast Cancer Colorectal Cancer (Female) Colorectal Cancer (Male) Prostate Cancer 
      AOR 95% CI Sig. AOR 95% CI Sig. AOR 95% CI Sig. AOR 95% CI Sig. 
Last Flu Immunization    
  
    
 
    
 
    
 
  
  < 1 Year 1 - 5 Years 1.44 [1.16,1.80] ** 0.81 [0.53,1.22] 
 
1.29 [0.83,2.02] 
 
1.12 [0.89,1.42]   
  
 
5 < Years 1.16 [1.01,1.33] * 1.01 [0.75,1.35] 
 
0.78 [0.56,1.08] 
 
1.13 [0.93,1.37]   
Last Physical Check-up 
   
  
  
  
  
  
 
  
  < 2 Years 1 - 5 Years 1.15 [0.74,1.79] 
 
2.04 [0.99,4.22] 
 
0.99 [0.48,2.03] 
 
1.29 [0.81,2.06]   
  
 
5 < Years 1.14 [0.91,1.44] 
 
0.92 [0.52,1.62] 
 
0.42 [0.24,0.74] ** 1.06 [0.75,1.48]   
Last Cholesterol Check 
   
  
  
  
  
  
 
  
  < 2 Years 1 - 5 Years 1.35 [0.90,2.02] 
 
2.24 [0.81,6.20] 
 
0.78 [0.35,1.74] 
 
1.46 [0.92,2.34]   
  
 
5 < Years 0.97 [0.76,1.24] 
 
0.66 [0.39,1.12] 
 
0.51 [0.28,0.95] * 0.89 [0.63,1.26]   
BMI (Underweight/Normal)  
  
  
  
  
  
  
  
  
  Obese 1 - 5 Years 0.82 [0.62,1.08]   0.59 [0.35,0.99] * 1.51 [0.86,2.64]   0.89 [0.65,1.23]   
  
 
5 < Years 1.29 [1.02,1.64] * 1.13 [0.77,1.66]   0.82 [0.55,1.23]   0.85 [0.67,1.07]   
  Overweight 1 - 5 Years 0.78 [0.67,0.92] ** 0.65 [0.40,1.08]   1.39 [0.83,2.32]   0.97 [0.75,1.25]   
  
 
5 < Years 0.92 [0.79,1.06]   1.09 [0.80,1.48]   0.85 [0.60,1.21]   1.06 [0.87,1.28]   
Physical Activity (Recommended) 
   
  
 
  
  
  
  
  
  None 1 - 5 Years 0.79 [0.57,1.09] 
 
0.42 [0.23,0.77] ** 0.98 [0.56,1.70]   0.65 [0.48,0.89] ** 
  
 
5 < Years 0.88 [0.73,1.07] 
 
1.13 [0.79,1.61] 
 
1.13 [0.74,1.71]   0.87 [0.68,1.10]   
  Insufficient  1 - 5 Years 1.01 [0.81,1.27] 
 
1.16 [0.72,1.88] 
 
1.25 [0.78,2.01] 
 
1.09 [0.86,1.39]   
  
 
5 < Years 0.95 [0.83,1.10] 
 
1.41 [1.03,1.94] * 1.33 [0.95,1.86] 
 
1.04 [0.86,1.26]   
Fruits & Vegetables  
   
  
  
  
  
  
 
  
  5 < Servings/Day 1 - 5 Years 1.39 [1.13,1.72] ** 0.86 [0.55,1.34] 
 
0.81 [0.47,1.41] 
 
1.11 [0.85,1.44]   
  
 
5 < Years 1.07 [0.93,1.23]   0.80 [0.60,1.08] 
 
0.91 [0.66,1.27] 
 
0.85 [0.70,1.04]   
Smoking Status (Never Smoked) 
  
  
  
  
  
  
  
  
  Current 1 - 5 Years 0.63 [0.45,0.87] ** 0.94 [0.46,1.90]   0.61 [0.34,1.11]   0.77 [0.52,1.14]   
  
 
5 < Years 0.90 [0.71,1.15]   1.15 [0.72,1.86]   0.82 [0.44,1.52]   0.73 [0.52,1.03]   
  Former 1 - 5 Years 1.08 [0.87,1.33]   1.28 [0.85,1.94]   0.85 [0.52,1.39]   0.79 [0.63,1.00]   
  
 
5 < Years 1.01 [0.89,1.15]   1.30 [0.95,1.79]   1.00 [0.74,1.35]   0.89 [0.75,1.06]   
Alcohol Consumption   
   
  
  
  
  
  
 
  
  Drink Any 1 - 5 Years 1.08 [0.88,1.34] 
 
1.02 [0.63,1.67] 
 
0.92 [0.60,1.41] 
 
1.17 [0.93,1.48]   
    5 < Years 1.09 [0.95,1.25]   1.18 [0.84,1.66]   0.90 [0.65,1.24]   0.97 [0.82,1.16]   
Abbreviations: AOR, Adjusted Odds Ratios; CI, Confidence Intervals; BMI, Body Mass Index; CVD-MS, Cardiovascular Disease-Metabolic Syndrome; 
CVD-MD includes the presence of heart disease, high cholesterol, hypertension, and or diabetes.  
    Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
  Reference categories for dependent variables are as follows: Last Flu Immunization (> 1 Year), Last Physical Check-up (> 2 Years), Last Cholesterol Check-up (> 2
Years), Alcohol Consumption (No Drinks in Past 30 Days),   
Fruits & Vegetables (5 > Servings /Day), Smoking Status (Never Smoked), BMI (Underweight/Normal), Physical Activity (Recommended Level).   
Results shown are adjusted for the following covariates: Presence of Cancer (no), Race/Ethnicity (White), Age (18 - 54), Marital Status (married),  
Metro Status (non-metro), Region of U.S. (Northeast), Education (< high school), Employment Status (not employed), Income (< $25,000),   
Health Insurance (no), Usual Source of Care (no), Arthritis (no), Asthma (no), CVD-MS (no), and Stroke (no), Perceived General Health Status (fair/poor), 
Activity Limitations (no).  
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Table 5. 
Logistic Regression Comparison of Health Behaviors of Cancer Survivors by Cancer Type and Gender  
Behavioral Risk Factor Surveillance System, 2009 
    Breast Cancer  Prostate Cancer  Colorectal Cancer (Female)  Breast Cancer 
     Vs. Colorectal (Female) Vs. Colorectal (Male) Vs. Colorectal (Male) Vs. Prostate 
    AOR 95% CI Sig. AOR 95% CI Sig. AOR 95% CI Sig. AOR 95% CI Sig. 
Last Flu Immunization             
  
  
  
  
  < 1 Year 1.22 [0.93,1.60]   1.21 [0.91,1.61]   1.10 [0.78,1.54]   1.03 [0.86,1.23]   
Last Physical Check-up 
  
  
  
  
  
  
  
  
  < 2 Years 0.94 [0.55,1.59]   1.68 [0.97,2.91]   1.72 [0.91,3.27]   0.86 [0.62,1.19]   
Last Cholesterol Check 
  
  
  
  
  
  
  
  
  < 2 Years 1.00 [0.59,1.70]   1.32 [0.77,2.25]   1.38 [0.73,2.59]   0.88 [0.63,1.23]   
BMI 
  
  
  
  
  
  
  
  
  Obese 0.78 [0.56,1.09]   0.96 [0.67,1.36]   0.69 [0.45,1.05]   0.57 [0.46,0.71] *** 
  Overweight 1.10 [0.83,1.45]   1.01 [0.74,1.38]   0.43 [0.30,0.61] *** 0.49 [0.41,0.59] *** 
Physical Activity 
  
  
  
  
  
  
  
  
  None 0.94 [0.69,1.28]   0.73 [0.51,1.04]   1.37 [0.91,2.05]   1.65 [1.31,2.06] *** 
  Insufficient  0.75 [0.57,0.98] * 0.74 [0.55,1.00]   1.41 [0.98,2.02]   1.28 [1.07,1.52] ** 
Fruits & Vegetables  
  
  
  
  
  
  
  
  
  5 < Servings/Day 1.20 [0.93,1.54]   1.00 [0.71,1.39]   1.76 [1.23,2.52] ** 2.29 [1.92,2.74] *** 
Smoking Status   
 
  
  
  
  
  
  
  
  Current 0.83 [0.56,1.23]   0.95 [0.58,1.56]   0.69 [0.41,1.17]   0.55 [0.41,0.73] *** 
  Former 0.84 [0.64,1.10]   0.92 [0.69,1.21]   0.47 [0.33,0.66] *** 0.44 [0.38,0.52] *** 
Alcohol Consumption   
  
  
  
  
  
  
  
  
  Drink Any 0.94 [0.69,1.27]   1.13 [0.86,1.49]   0.64 [0.45,0.92] * 0.54 [0.46,0.63] *** 
Abbreviations: AOR, Adjusted Odds Ratios; CI, Confidence Intervals; BMI, Body Mass Index; CVD-MS, Cardiovascular Disease-Metabolic Syndrome; 
CVD-MD includes the presence of heart disease, high cholesterol, hypertension, and or diabetes.  
   Asterisks represent significant differences compared to the reference group. *** p < .001, ** p < .01, * p < .05. 
 Reference categories for dependent variables are as follows: Last Flu Immunization (> 1 Year), Last Physical Check-up (> 2 Years), Last Cholesterol 
Check-up (> 2 Years), Alcohol Consumption (No Drinks in Past 30 Days),   
Fruits & Vegetables (5 > Servings /Day), Smoking Status (Never Smoked), BMI (Underweight/Normal), Physical Activity (Recommended Level).   
Results shown are adjusted for the following covariates: Presence of Cancer (No), Race/Ethnicity (White), Age (18 - 54), Marital Status (Married), 
Metro Status, (Non-Metro), Region of U.S. (Northeast),  
Education (< High School), Employment Status (Not employed), Income (< $25,000), Health Insurance (No), Usual Source of Care (No), Arthritis (No), 
CVD-MS (No), Perceived General Health Status (Fair/Poor),  
Activity Limitations (No).  
           Reference categories are given in parenthesis.  
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CHAPTER 4 
Study Findings 
 The number of cancer survivors has continued to grow in the U.S. and worldwide due to 
advances in early detection and treatment methods.  However, many cancer survivors continue to 
experience late and long-lasting symptoms and effects from the cancer and its treatment that 
diminish their Health-Related Quality of Life (HRQOL).  What is more, is that after surviving 
cancer, which may be considered a teachable moment, many cancer survivors do not engage in 
superior health behaviors compared to those who do not have a history of cancer.  Survivors of 
breast, prostate, and colorectal cancer are the three largest groups of cancer survivors and 
together comprise over 50% of survivors living in the U.S.  Few studies have HRQOL, heath 
conditions, and health behaviors among these groups of survivors to those without a history of 
cancer while rigorously controlling for known confounders.  Moreover, few studies have 
compared HRQOL between these groups of survivors by cancer type and gender.  It remains 
uncertain how survivors may differ in these aspects from those without a history of cancer and 
from one another.  Therefore, two studies were conducted to address these questions.  The first 
study compared domains of HRQOL among these groups of cancer survivors to propensity score 
matched controls and between type of cancer and gender.  The second study compared the 
prevalence of health conditions among these groups of survivors to propensity score matched 
controls, and also compared health behaviors among these survivor groups to propensity score 
matched controls and between cancer type and gender.   
 In the study of HRQOL among survivors of breast, prostate and colorectal cancer 
survivors to propensity score matched controls and by cancer type and gender, survivors were 
more likely to report worse outcomes for multiple domains of HRQOL, compared to matched 
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controls.  The number of domains that survivors reported worse outcomes than their matched 
controls varied according to type of cancer.  Compared to their matched controls, breast cancer 
survivors were more likely to report activity limitations and to perceive their general health as 
poorer at both 1 – 5 and > 5 years since diagnosis.  Female colorectal cancer survivors were also 
more likely to report activity limitations and have a poorer perceived general health both time 
periods, as well as reporting a greater number of bad physical health days in the past month, but 
greater life satisfaction for the first 1 – 5 years, compared to their matched controls.  Similar to 
the two groups of female cancer survivors, male survivors of colorectal cancer were also more 
likely to report activity limitations and hold poorer perception of their general health status for 
both time periods compared to their matched controls.  Male colorectal cancer survivors were 
also more likely to report a greater number of bad mental health days in the past month at 1 – 5 
years since diagnosis and more bad physical health days in the past month and poorer life 
satisfaction at > 5 years since diagnosis, compared to their matched controls.  Prostate cancer 
survivors were more likely to hold poorer perceptions of their general health at both times since 
diagnosis, and were also more likely to report a greater number of bad mental health days in the 
past month, a greater days of days they did not get enough sleep in the past month, and not 
receiving enough emotional support at 1 – 5 years since diagnosis, compared to their matched 
controls.   
 In the comparison of HRQOL between cancer types and genders, survivors of breast 
cancer were less likely to perceive their general health as poor or fair, compared to female 
colorectal cancer survivors.  Compared to male colorectal cancer survivors, survivors of prostate 
cancer were less likely to report activity limitations, perceive their general health as poor or fair, 
and less likely to report bad physical health days in the past month.  Compared to male colorectal 
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cancer survivors, female colorectal cancer survivors were less likely to report activity limitations, 
hold poorer perceptions of their general health and more likely to have greater life satisfaction, 
but were more likely to report more bad mental health days and day of not enough sleep in the 
past month and not receiving enough emotional support.  Compared to prostate cancer survivors, 
survivors of breast cancer were more likely to report a greater number of bad physical health 
days, bad mental health days, and not enough sleep in the past month, and not receiving enough 
emotional support.   
 In the study of health conditions and health behaviors, survivors of breast and prostate 
cancer reported a greater prevalence of certain chronic and comorbid health conditions compared 
to their matched controls than did female and male colorectal cancer survivors.  Compared to 
their matched controls, survivors of breast cancer reported a higher rate of arthritis, diabetes, 
high cholesterol, and activity limitations.  Compared to their matched controls, survivors of 
prostate cancer reported higher rates of arthritis, hypertension, high cholesterol, and activity 
limitations.  Female colorectal cancer survivors reported a greater number of activity limitations 
than their matched controls and male colorectal cancer survivors reported higher rates of asthma 
and activity limitations than their matched controls.   
 In the comparison of health behaviors between cancer survivors and their matched 
controls, breast cancer survivors demonstrated the most differences.  Compared to their matched 
controls, survivors of breast cancer at both times since diagnosis were more likely to have 
received a flu immunization in the past year, were more likely to consume > 5 servings of fruits 
and vegetables a day, less likely to be overweight and or a current smoker at 1 – 5 years after 
diagnosis, but were more likely to be obese at > 5 years since diagnosis, compared to their 
matched controls.  At 1 – 5 years since diagnosis, female colorectal cancer survivors were less 
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likely to be obese, and less likely to no physical activity, but at > 5 years after diagnosis they 
were more likely to get insufficient levels of physical activity compared to their matched 
controls.  Compared to their matched controls, male colorectal cancer survivors at > 5 years 
since diagnosis were less likely to have had a physical check-up of a blood cholesterol check in 
the past 2 years.  Prostate cancer survivors were only different from their matched controls in 
that they were less likely to get no physical activity at 1 – 5 years since diagnosis.  
 The comparison of health behaviors between cancer types and genders, few differences 
were observed between cancer types.  Compared to female colorectal cancer survivors, survivors 
of breast cancer were less likely to engage in insufficient levels of physical activity.  
Comparisons of health behaviors between genders revealed a greater number of differences. 
Compared to male colorectal cancer survivors, female colorectal cancer survivors were less 
likely to be overweight, be a former smoker, or consume any amount of alcohol, and more likely 
to consume > 5 servings of fruits and vegetables a day.  Additionally, while not significant, 
female colorectal cancer survivors tended to be more likely to engage in none or insufficient 
levels of physical activity than male colorectal cancer survivors.  Compared to prostate cancer 
survivors, survivors of breast cancer were less likely to be overweight and/or obese, to be current 
and/or former smokers, drink any amount of alcohol, and more likely to consume > 5 servings of 
fruits and vegetables a day, but they were more likely to engage in none or insufficient levels of 
physical activity.   
Summary & Conclusions 
 Overall, this study has shown that breast, female colorectal, male colorectal and prostate 
cancer survivors experience worse HRQOL of life outcomes than do similar individuals without 
a history of cancer.  The magnitude of the differences in health behaviors between cancer 
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survivors and controls varied by type of cancer.  However, the most notable differences appear to 
have been related to gender differences.  Certain aspects of HRQOL may be more adversely 
affected among male survivors than female survivors when they are compared to matched 
controls.  These differences may be related to differences in higher levels of physical activity 
prior to cancer and the greater expectations for physical functioning among men than women.  
Therefore, the limiting effects of cancer and its treatment upon physical functioning may more 
negatively affect mental health psychosocial well-being among male cancer survivors compared 
to female cancer survivors.  Previous research has documented relatively high rates of 
depression, anxiety, and sleep disturbances among women, with rates being higher than those 
observed in men.  Therefore, when female cancer survivors were compared to female controls, 
no differences were observed in relation to mental health, psychosocial well-being and quality of 
sleep.  Yet, when female cancer survivors were compared to male cancer survivors, women 
demonstrated worse outcomes for these measures.   
 Similarly to the findings regarding HRQOL, while there was variation in health behaviors 
according to cancer type, with breast cancer survivors seeming to engage in better health 
behaviors than their controls, more differences emerged in the gender comparisons between 
cancer survivors.  Female cancer survivors had better health behaviors than did male cancer 
survivors, with the exception that prostate cancer survivors engaged in more physical activity 
than did breast cancer survivors.  Thus, cancer survivors do have worse HRQOL outcomes than 
do similar individuals without a history of cancer, but health behaviors between the two groups 
may vary according to cancer type.  However, when women are compared to men, observed 
patterns regarding HRQOL and health behaviors appear to be similar to those in the general 
population.  
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Strengths & Limitations 
 This study was conducted using a large national, population-based sample of cancer 
survivors representing a wide range of ages and times since diagnosis.  Confounding effects in 
survivor vs. control comparisons were robustly controlled for using the propensity score 
matching method.  This study was able to compare a diverse range of measures of HRQOL and 
health behaviors between survivors and controls, for both short and long-term cancer survivors.  
However, this study’s effort to control for confounding effects were limited by the lack of 
information concerning type of treatment received and stage at diagnosis among cancer 
survivors.  Additionally, outcomes could not be measured for survivors who have died.  
Therefore, it is uncertain outcomes for HRQOL and health behaviors would have affected study 
findings.  Finally, this study was conducted using self-reported data that may contain responder 
bias.   
Study Implications & Future Research 
 Hormone treatment related weight gain, obesity related diseases, and the symptoms and 
effects affecting the HRQOL of survivors of breast, prostate, and colorectal cancer should be 
monitored for as closely as cancer recurrence.  Educating survivors before treatment about the 
benefits of health behaviors and possible symptoms and effects they may experience after 
treatment, as well as providing them with information regarding treatment or coping mechanisms 
for these symptoms and effects before cancer treatment may help survivors maintain a good 
HRQOL throughout the survivorship continuum.  Moreover, education health care professionals 
who provide care for cancer survivors as to these issues and possible differences among types the 
cancer survivors and genders could help them to identify needed interventions. 
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 As cancer detection and treatment strategies improve, the population of other types of 
survivors will also grow.  Therefore, studies of this kind should be replicated among other types 
of cancer survivors.  Future research efforts should be directed towards developing and 
evaluating educating and intervention plans that are intending to improve the health status and 
HRQOL of cancer survivors.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
88 
 
Traci LeMasters M.S, M.A, B.S. 
Graduate Student/Research Assistant 
Department of Pharmaceutical Systems and Policy 
School of Pharmacy 
West Virginia University 
(304) 293-8194 
tlemasters@hsc.wvu.edu 
________________________________________________________________________ 
 
Education: 
 
 Complete Master of Science in Pharmaceutical Sciences   
WVU School of Pharmacy 
Morgantown, WV 
Degree to be conferred, May 2012 
 
    Master of Arts in Secondary Education in General Science 
      West Virginia University 
      Morgantown, WV 
      Degree conferred, December 2006    
       
    Bachelors of Science in Psychology 
      West Virginia University 
      Morgantown, WV 
      Degree conferred, August 2004 
       
 Salutatorian of Nicholas County High School graduating class of 2000 
 
Professional Experience: 
 
 West Virginia University Graduate Research Assistant for the West Virginia Collaborative 
Health Outcomes of Research of Therapies and Services Center 
 (WV CoHORTS) 
- Morgantown, WV 
- Entered survey data collected from women who utilized the Bonnie Wells Wilson Mobile 
Mammography Program and who agreed to participate in a study being conducted by 
the WV CoHORTS Center 
- Conducted literature review for anticipated manuscripts from the research study of the 
Bonnie Wells Wilson Mobile Mammography Program 
 
 West Virginia University Teaching Assistant for the School of Pharmacy’s Professional 
Program 
- Morgantown, WV 
- Lead small group lab activities for 1st year students 
89 
 
- Graded various assignments, quizzes, and tests 
- Managed various aspects of the official school SOLE  web page pertaining said classes 
- Assisted in administering exams 
 
    South Middle School Teaching Intern, August 23 - October 11 2006 
- Morgantown, WV 
- Designed and implemented lesson plans according to WV Curriculum Standards for 7th 
grade Science 
- Organized classroom atmosphere and managed student behavior 
 
 East Fairmont High School Teaching Intern, October 13 – December 13 2006 
- Fairmont, WV 
- Designed and implemented lesson plans according to WV Curriculum Standards for 9th 
grade Science, Earth Science and Conceptual Biology 
-    Organized classroom atmosphere and managed student behavior 
 
 West Virginia University Department of Psychology Behavioral Analysis Lab Intern, 
January – May 2004 
- Morgantown, WV 
- Computed data analysis 
- Observed and categorized  child behavior 
- Participated in professional article reviews 
 
 Chestnut Ridge Department of Psychological Testing Intern, January – May 2003 
- Morgantown, WV 
- Administered and scored a variety of psychological tests 
- Participated in professional article reviews 
 
 West Virginia University Residential Assistant, January – May 2003 
- Morgantown, WV 
- Managed and disciplined behavior of dormitory residents 
- Designed and implemented social activities 
- Managed the front desk 
 
Honors/Activities 
 
 Member of Rho Chi National Pharmacy Honor Society 
 
 National member of the International Society for Pharmacoeconomics and Outcomes 
Research 
 
 National member of the Golden Key International Honor Society 
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 2009 – 2011 Secretary for the WVU Student Chapter of ISPOR 
- Write agenda for monthly meetings 
- Record minutes of monthly meetings 
 
 2008 – 2010 Member of the WVU Student Chapter of ISPOR 
- Chair of the WVU ISPOR Potluck Fundraiser Committee for Fall and Spring Potlucks 
 
 
 
Publications 
 
 “A National Study of Out-of-Pocket Expenditures for Mammography Screening” Traci 
LeMasters M.A. & Usha Sambamoorthi PhD.   
 
Analysis of out of pocket expenditures for women age 40 – 64 years of age receiving 
mammograms and factors correlating with higher and or lower out of pocket expenditures 
among a nationally representative sample 
 
Data is from the Medical Expenditure Panel Survey 2006 – 2007 
Used SAS software to analyze data 
 
Accepted for publication in the October, 2011 Issue of the Journal of Women’s Health 
 
 
Manuscripts to be Submitted for Publication  
 
 A comparison of health behaviors and health status between survivors of breast, prostate 
and colorectal cancers and to propensity score matched non-cancer controls, as well as, 
comparisons by cancer type and gender 
-   Data is from 2009 BRFSS 
-   Used SAS to conduct analysis 
 
 A comparison of the HRQOL between survivors of breast, prostate, and colorectal cancers 
among survivors to propensity score matched controls, as well as, comparisons by cancer 
type and gender 
-   Data is from 2009 BRFSS  
-   Used SAS to conduct analysis 
 
 “A Study of Relationships between Perceived and Actual Risk of Breast Cancer and 
Mammography Utilization among Women Attending a Mobile Mammography Program in a 
Rural Appalachian State” 
Traci LeMasters, M.A., Suresh Madhavan, Ph.D., Elvonna Atkins, M.S.c, Ami Vyas, M.S., 
M.B.A., Susan Faulkner, Ed.D., Sara Jane Gainor, M.B.A., Stephenie Kennedy, M.A., Scott 
Remick, M.D., & Linda Vona-Davis, Ph.D. 
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Model of the relationship between mammography utilization, perceived risk, actual risk and 
other psychosocial and individual characteristics among women attending the Bonnie Wells 
Wilson Mobile Mammography Program 
 
Data is from the Bonnie’s Bus Mammography Screening and Preventive Care Survey Years 
2009 & 2010 
Used SPSS software to analyze data 
 
Assisting Research 
 
 “Young Adult Smoking Cessation in West Virginia: Attitudes, Perceptions, and Quitting 
Methods.” Cindy Tworek, PhD, MPH1,2, Robin Danek, MPH3, Traci LeMasters, MS2, Traci 
Jarrett,MA1,3 , Kimberly Horn, EdD, MSW1,3  
 
Posters 
 
 “A National Study of Out-of-Pocket Expenditures for Mammography Screening” – presented 
at the Fall 2010 WVU School of Pharmacy Research Day and at the 2011 Annual 
International Meeting of the International Society for Pharmacoeconomics and Health 
Outcomes Research conference in Baltimore, MD. 
 
 “A Study of Relationships between Perceived and Actual Risk of Breast Cancer and 
Mammography Utilization among Women Attending a Mobile Mammography Program in a 
Rural Appalachian State” -  
      Presented at the Spring 2011 WVU Health Sciences Van Lier Research Day and at      
      the 2011 Annual Women’s Health Conference in Crystal City, VA. 
 
 
Presentations 
 
 “Propensity Score Modeling in Health Outcomes Research” 
- Graduate Seminar, Spring 2012 
 
 “Conceptual Frameworks for Studies of Health Care Quality” 
- Graduate Seminar, Fall 2011 
 
 “The Role of Cost in Comparative Effectiveness Research.” 
- Graduate Seminar, Spring 2011 
 
 “Absolute and Perceived Risk of Breast Cancer among Women and Associations with 
Mammography Utilization.” 
- Graduate Seminar, Fall 2010 
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 “Breast Cancer Survivorship: Survivorship Care Plans & Modifiable Lifestyle Factors.” 
- Graduate Seminar, Spring 2010 
 
 “A Cost-effective Analysis of Donepezil, Galantamine, Memantine, and Rivastigmine for the 
Treatment of Mild to Moderate and Moderate to Severe Stages of Alzheimer’s Disease in the 
United States: Study Proposal.” 
- Graduate Seminar, Fall 2009 
 
 “Effects of Various Alzheimer’s Disease Drug Treatment Options on Caregiver Burden 
Associated with Neuropsychiatric Disturbances” 
- Patient Reported Outcomes Class, Fall 2009 
 
 “Health Disparities Among the American Indian/Alaska Native Population:  A Focus on 
Prenatal Care.” 
- Graduate Seminar, Spring 2009  
 
 “Health Disparities in Prenatal Care Resulting in Poor Birth Outcomes in West Virginia.” 
- Health Disparities Class, Spring 2009 
 
 “Zomepirac sodium: The History of its Entrance and Withdrawal from the Market.” 
- Pharmacoepidemiology Class, Spring 2009 
 
 “Thalidomide: The Harm Done and Lessons Learned.” 
- Pharmacoepidemiology Class, Spring 2009 
 
 “A Cost Benefit Analysis of West Virginia’s redesigned Medicaid program, Mountain Health 
Choices, Affecting Adults and Children.” 
- Pharmacoeconomics Class, Fall 2008  
 
 “Stay The Course: An Intervention to Target Patient Compliance of Antibiotic Therapy for 
Respiratory Tract Infections among Medicare Part D Recipients Utilizing Medication Therapy 
Management Programs.” 
- Social & Behavioral Theory Class, Fall 2008 
 
 “Social Network Theory.” 
- Graduate Seminar, Fall 2008 
 
Miscellaneous 
 
 Served as a review for the Journal of Health Care for the Poor and Underserved 
- Jan – April, 2012 
 
